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ABSTRACT 
 
Dengue stands out from other viral mosquito borne diseases because it is the most 
common; its incidence is growing and it is reaching new geographical areas and spreading 
worldwide. Indeed, reported cases of negative pregnancy outcomes after dengue infection 
is not new, however, the evidence of the association between maternal dengue and 
adverse pregnancy outcomes is limited, controversial and mostly supported by cases 
reports. The aim of this thesis is to explore the relationship between pregnancy outcome 
and symptomatic maternal dengue.  
I conducted a population-based study using routinely-collected Brazilian data 
from 2006-2012. These data have the information required to expand the existing 
knowledge on birth outcomes from women with dengue acquired during pregnancy.  
The linkage process imposed complex challenges, and the final linked data 
showed a low sensitivity. However, it is unlikely that the linkage error introduced bias on 
the final analysis since it occurred randomly between cases and the comparison group.   
Our main findings showed that dengue during pregnancy is associated with 
adverse maternal and birth outcomes. The effect was higher in the acute disease period 
(first 10/20 days) and severe disease increased the magnitude of the association. Therefore 
in areas where dengue virus is circulating, the health of pregnant women should be not 
only a public health priority, but health professionals attending pregnant women with 
dengue should more closely observe these patients to be able to intervene in a timely way 
and avoid adverse outcomes.   
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Literature review section  
Overview  
 Currently the attention given to adverse pregnancy outcomes of maternal infection 
is growing and the volume of published studies in this particular field have increased 
substantially in the last two years. Much of this sudden interest can be attributed to the 
association between Zika infection during pregnancy and microcephaly.   
The discovery of this new association has heated the debate of the harmful effects 
of maternal infections. Before Zika, only rare cases of adverse birth outcomes had been 
linked to a virus belonging to the genus flavivirus within the Flaviviridae family, such as 
West Nile virus 1. In general, studies on the negative outcomes of viral maternal infection 
is limited, with some exceptions.  
It is particularly important to investigate the effects that arboviruses (i.e. virus 
transmitted by the bite of an infected arthropod, mainly mosquitos and ticks) 2 in the 
course of gestation produce on the mother and their fetus. This interest is mainly because 
some of them are already endemic in many countries, particularly in America and South 
East Asia, such as dengue virus. Others are emerging and spreading to new areas (e.g. 
Chikungunya and Zika). Control measures are failing and no vaccine is available for most 
of them.   
The first chapter of this thesis is a non-systematic literature review that provides 
a global perspective of the most discussed maternal infections and their effects on 
pregnancy outcomes focusing on maternal mortality, stillbirth, preterm birth, low birth 
weight and small for gestational age and second presents some biological mechanisms to 
show how infections can affect outcomes (Table 1). There are more adverse fetal 
outcomes associated with maternal infections than those discussed in this literature 
17 
 
review, such as early pregnancy loss, congenital anomalies, neonatal deaths and long term 
disability (cerebral palsy psychiatric disease)3, however, they will not be addressed here 
because they were not investigated in this study.  
The literature on maternal dengue infection and potential outcomes associated 
with this disease will be discussed in the next chapter in detail.  
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Chapter 1. Introduction on adverse outcomes of maternal infection during 
pregnancy   
 
Maternal infection  
 Successful pregnancy is an example of immunological tolerance that women must 
endure to encompass paternal antigens expressed by the fetus. Although maternal-fetal 
tolerance is not fully understood, it is known that immunological competence changes in 
the mother. There is evidence that pregnancy induces shifts in her systemic immune 
responses and maternal regulatory T cells. With the progress of the pregnancy, a general 
shift from T-helper type 1(Th1) cell-mediator immunity to T-helper type 2 (Th2) occurs 
4. Nonetheless, this expanded tolerance can result in susceptibility to infection. This 
system is very complex, and resistance against most pathogens is not significantly 
compromised with pregnancy, except intracellular organisms, for example Toxoplasma 
gondii 5,6. Furthermore, it has been proposed that strong Th1 response may overcome 
protective T-regulatory and Th2 activity, leading to fetal loss 5.   
When acquired during pregnancy, infections can make women more prone to 
complications, an example is the increased susceptibility to influenza A during pregnancy 
and pregnant women have higher rates of hospitalization and mortality compared with 
non-pregnant peers 6–9. Among all pregnancy related deaths, infections account for over 
12% and when the outcome is a miscarriage or stillbirth, the role of maternal infections 
is even higher, 39% and 16% respectively 10. During pregnancy, those women, with an 
infectious disease are more likely to suffer maternal deaths than non-infected pregnant 
women, for example, measles and tuberculosis have been found to increase the risk of 
maternal deaths 9 11 and 4 fold respectively 12.  
Infections in pregnant women can either resolve themselves spontaneously or 
require treatment. Some remain localized and have no effect on the fetus, however, the 
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infecting agent may perhaps invade the bloodstream and subsequently infect the placenta 
and fetus. Invasion of the maternal bloodstream is common, yet in most cases, neither 
fetal nor placental infection results. In general the fetus is protected by maternal innate or 
pre-existing immunity. However, even without direct microbial invasion the fetus can be 
affected by fever, anoxia, toxins and hematologic impairments in the mother that disturb 
the pregnancy resulting in abortion, stillbirth, premature delivery, growth retardation 5.  
The effects of infections on birth outcomes  
 The relationship between adverse fetal outcomes and maternal infection with a 
variety of microorganisms (bacteria, viruses, or protozoa) has been widely debated in the 
literature. However, the role of maternal infection on negative fetal outcomes has still not 
been consistently defined and appears to vary according to the pathogen involved, the 
gestational age and the severity of the maternal disease 13–16.  
Table 1: maternal infections and adverse pregnancy outcomes  
Stillbirth 
Stillbirth can be defined as the death of a product of conception before the 
expulsion or complete extraction from the body of the pregnant woman, occurring after 
22 week of pregnancy or fetus weighing more than 500g 17. However, gestational age and 
birth weight limits that distinguish a spontaneous abortion from a stillbirth vary across 
studies and regions 13, ranging from 20-28 weeks. Infection is more clearly associated 
with early (20-28 weeks) compared with late stillbirth, with an increasing proportion of 
infected-related stillbirth at lower birth weights 18In this literature review, we considered 
the definition of stillbirth presented by the authors of each study, independent of 
gestational age or weight limits used. Stillbirth rates differ around the world: modelled 
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estimates calculate that in high income countries the rate of stillbirth is  4/1000 birth, 
compared with 26/1000 birth in low-middle income countries 19.   
Infection can cause stillbirth by a variety of mechanisms. The intrauterine death 
may be a result of an overwhelming fetal infection, or the microorganism may interfere 
with organogenesis to such extent that viability is interrupted 5. Spontaneous termination 
can occur when the maternal infection leads to systemic illness where the mother is 
severely ill and the fetus may die without the organism being transmitted to placenta or 
the fetus, or the placenta may be directly infected resulting in reduced blood flow to the 
fetus 18. Finally, the infection may precipitate preterm labour, and some of these fetuses 
are too small to survive birth by caesarean section or vaginal labour and are born dead 18.  
 Estimates suggest that the worldwide proportion of antepartum stillbirth rate due 
to maternal infections and chorioamnionitis (colonisation, infection, and inflammation of 
the placenta and its membranes 20) is approximately 5%.  In most cases, however, the 
cause of stillbirth is unknown 19, so the real role of infections on birth outcomes is likely 
to be underestimated 16, especially in low-income countries, which normally have higher 
rates of maternal infection and stillbirth 3. The proportion of infection related to stillbirth 
in early gestational age tend to be higher than in late stillbirths 21,22. In high income 
countries, infections accounted for 15% of stillbirths at less than 28 weeks and 6% of 
stillbirth at more than 28 weeks’ gestation 23.   
Ascending bacterial infection is the most common infectious cause of stillbirths 3.  
These bacteria ascend from the vagina into the uterus, during early pregnancy or even 
before pregnancy, and enter the amniotic fluid and ultimately infect the fetus 13,24. From 
all the bacterial infections associated with stillbirth, special emphasis should be given to 
group B streptococcal (GBS) infection. The rates of GBS-related stillbirths range from 
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0.04/1000 births in England 25 to 0.9/1000 births in USA and the proportion of GBS 
among infection related stillbirth could be as high as 50% 26.    
In areas where syphilis has a high prevalence, more than 20% of all stillbirths are 
attributed to this disease 27,28. The most common cause of these deaths appears to be 
placental infection associated with decreasing blood flow to the fetus. Spirochetes also 
can cross the placenta and infect the fetus which can either die in utero or be born alive 
with congenital syphilis 18.  
Malaria is well known as cause of growth restriction, however the risk of stillbirth 
caused by this disease is difficult to estimate in most populations because, when the 
prevalence of malaria is high, it does not exist in isolation from other factors 18. A 
systematic review showed that placental malaria (primarily in endemic areas) was 
associated with a higher risk of stillbirth, even after adjusted for parity (OR=2.2, 95% 
CI=1.5-3.2) 29. In Ethiopia, areas with unstable transmission women with placental 
parasitemia was associated with 7-fold increased risk of stillbirth, compared with 
aparasitemic women 30.   
Viral infections are involved in the occurrence of stillbirth, however, the 
pathological mechanisms and its importance as a cause of stillbirth are unclear, possibly 
because even in high income countries, virus culture and identification is complex and 
expensive 16,31. The proportion of stillbirths due to viral infections have been estimated at 
14.5% 32. However, it is possible that a proportion of unexplained stillbirths could be 
undiagnosed viral infections 33. Parvovirus B-19 as a cause of stillbirth has been described 
since 1984 and it seems to be one of the better understood mechanisms of how a virus 
can result in a fetal death. This virus can cross the placenta, infecting fetal erythropoetic 
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tissue, producing fetal anaemia, resulting in hydrops and fetal death 34–36. It also can attack 
cardiac tissue and cause stillbirth 18. 
The magnitude of the association between maternal viral infection and stillbirth 
varies given the pathogen, the severity of the maternal illness, the gestational age and 
other factors. For example, maternal influenza requiring hospitalization was found to 
increase the risk of fetal death odds ratio 4.2 (95% CI 1.4-12.4) 7, whereas the risk of 
stillbirth in pregnant women with a mild disease was 1.9 (95% CI 1.1-3.4), using women 
who were pregnant outside the pandemic as reference 37. The risk ratio of stillbirth among 
women with HIV infection was 1.67 (95% CI 1.0-2.6) compared to women without the 
disease 38. More recently, emerging viral diseases, such as Ebola and Zika, have been 
associated with stillbirth although the magnitude and mechanisms of these associations 
remain unknown 39–42.     
Prematurity  
Preterm birth, defined as birth at less than 37 weeks of gestation 43, is responsible 
for a significant proportion of infant mortality 44 and neurological disorders including 
delay in development 45.  The prevalence of preterm birth varies from about 5% in 
European countries to 18% in some African countries 46, although the rates in lesser 
developed regions may be underestimated due to lack of country-level data 46. There are 
three main precursors of preterm birth. The first one is the delivery for maternal or fetal 
indication, in which the labour is induced or the infant is delivered by caesarean section. 
These in general account for 30%-35% of all preterm labour. The second one is 
spontaneous preterm labour with intact membranes, this accounts for 40% - 45% of all 
preterm labour. Finally preterm premature rupture of membranes (PPROM), 
corresponding to 25%-30% of all preterm births 43. Preterm can also be divided by 
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gestational age, less than 28 weeks (extreme prematurity), at 28–31 weeks (severe 
prematurity), at 32–33 weeks (moderate prematurity), and at 34–36 weeks (late preterm) 
43.   
There are many maternal factors associated with preterm birth, such as 
demographic and economic status, nutritional status, pregnancy history, psychological 
characteristics, behaviours, biological markers and infection 43. Systematic and 
intrauterine infections are a frequent precursor of preterm birth, predominantly in early 
gestational ages 15,47.  
Bacterial intrauterine infection is the most frequent infection associated with 
preterm birth 43, accounting for 25-40% of preterm births 15. The mechanism involves the 
host response to infection, when the pathogen is recognised by receptors increasing the 
production of pro-inflammatory cytokines and chemokines (e.g., interleukin 8, 
interleukin 1β, and tumour necrosis factor-TNF α)  which can stimulate prostaglandin 
synthesis by the amnion and decidua and inhibit progesterone synthesis, stimulate uterine 
contractility, cervical ripening and the rupture of membranes resulting in preterm birth 
15,43,48. The most common pathogens reported in the amniotic fluid are Mycoplasma 
hominis and Ureaplasma urealyticum, but other organisms have been isolated 3.  Other 
bacterial infections such as periodontitis, bacterial vaginosis, urinary tract infection and 
systemic infections such as appendicitis have been associated with increasing preterm 
birth risk, however, the pathological mechanisms are unknown 3,15,49–54. 
Compared to bacterial infection, evidence on the association between maternal 
viral infection and preterm birth is limited.  In cases where the mother develops a severe 
systemic illness a preterm delivery can occur 3. However, in absence of systemic severe 
disease, the evidence that maternal viral infection leads to preterm birth is contradictory 
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and mainly based on case reports 7,38,55–60. It seems unlikely that maternal viral infection 
plays a very important role in preterm birth; however, further research should clarify this.  
Intrauterine growth restriction and low birth weight    
The World Health Organization (WHO) defines low birth weight (LBW) as born 
alive weighing less than 2,500g 61. The prevalence of LBW is monitored through health 
system surveillance and household surveys. In 2013, approximately 22 million newborns 
(16% of all births) had LBW. However, this is probably underestimated since half of the 
world’s infants are not weighed at birth 62. A study estimated that in low and middle-
income countries in 2010 36% of livebirths (43.3 million infants) were born either 
preterm or small for gestational age (SGA).  The LBW definition can include infants with 
intrauterine growth restriction (IUGR), - birth weight lower than the 10th percentile for 
sex and gestational age specific 63 and preterm births 64. Small for gestational age is 
generally used as proxy of IUGR. Overall in low and middle income countries, of 18 
million low birth weight infants, 59%  were born term-SGA, whereas 41% were born 
preterm, (from those born preterm, 16% preterm and small for gestational age and 25% 
preterm with appropriate size specific for gestational age and sex64. 
Low birth weight and growth retardation have been associated with infant 
mortality, as well as short and long term morbidity. Studies have shown that the earlier 
the gestational age and the lower the birth weight and the degree of growth restriction, 
the higher the risk of neurological complications, especially cerebral palsy.  The estimated 
prevalence of term birth but small for gestational age in low and middle income countries 
ranges from 5.3% of livebirths in East Asia to 41.5% in South Asia 64. 
 There are many maternal factors associated with growth retardation, such as low 
maternal weight, smoking, preeclampsia, toxic exposure and infections 3. Between 5-15% 
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of all IUGR are of infectious origin 65, however, studies into the overall impact of 
maternal infectious diseases as a cause of LBW are limited, especially in developed 
countries where growth retardation appears associated with other factors such as below 
average maternal size, poor nutrition status, hypertension. Therefore, in this settings it is 
difficult to estimate the portion of growth retardation explained only by infectious 
aetiology 3.   
Maternal infections with TORCH (toxoplasmosis, rubella, cytomegalovirus, 
herpes virus and syphilis) are the main infections associated with growth retardation 66. 
The mechanism proposed for this relationship is fetal cell death caused by direct infection 
or by changes in placental or fetal blood flow.  
Intra uterine growth restriction is the principal fetal outcome related with malaria, 
which accounts for about 70% of IUGR in some regions 67,68, especially in primigravidae. 
The risk of low birth weight associated with malaria can be two to seven times higher for 
primigravid than multigravida women 67. A modelling study carried out in Africa in 2010 
estimated that without pregnancy-specific protection, 12.4 million pregnant women 
would have been exposed to malaria, with 92% of these having placental infection that 
leads to an estimated 900,000 low birth weight deliveries per year 69.  
  In addition to the viral infections contained in the TORCH (rubella, 
cytomegalovirus and herpes), HIV has been associated with an increased risk of low birth 
weight and small for gestational age (60% and 30% respectively 38. More recently, 
maternal exposure to Zika virus infection has been related with negative pregnancy 
outcomes. In the first cohort study published on Zika-related adverse outcomes, 9% of 
the Zika-exposed babies were small for gestational age compared with 5.3% of babies in 
control group 70.    
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Summary  
 Maternal and fetal adverse outcomes associated with infection, which occurred 
during pregnancy, have been studied for many years and there is enough evidence to 
conclude that some infections might lead to stillbirth, preterm birth and growth 
retardation. For example, there is extensive evidence about the role of maternal bacterial 
infections on preterm birth. However, the literature on the effects of maternal viral 
infection is controversial and scarce. Therefore, the occurrence of Zika highlighted the 
importance of carefully investigating the relationship between pathogen-specific maternal 
viral infection and pregnancy outcomes. The Zika emergence showed how little we know 
about the role of arbovirus on adverse fetal and maternal outcomes, even for dengue, that 
has been endemic in numerous countries for many years, there is not much information. 
In the next chapter, we will review the general literature on dengue and its association 
with pregnancy outcomes.   
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Table 1: Maternal infections and adverse pregnancy outcomes  
Organism  Outcome  Comment  
Treponema pallidum  Stillbirth 27,28,71–74 
Preterm birth 27,28,54,72,75 
Low birth weight  27,28,54,72,73,75 
In countries where the maternal prevalence is high, 
syphilis is a signficant cause of adverse pregnancy 
outcomes, especially when untreated. 
Neisseria gonorrhoeae Stillbirth 76 
Preterm birth 54,77–79  
Low birth weight 54,80,81 
Sexually transmitted disease seems to play a role in 
prematurity and low birth weight although this 
relationship may be being confounded by other risk 
factors. Association with stillbirth has just been 
documented by case reports.    
Chlamydia trachomatis Stillbirth 79,82,83 
Preterm Birth 79,83–87 
Low Birth Weight 88 
 
This sexually transmitted disease seems to play a role 
in prematurity. On the other hand, the association 
between Chlamdya and low birth weight and stillbirth 
is controversial and should be better investigated.  
group-B streptococcus Stillbirth  24,25,89–92 
Preterm birth 93–96  
Low birth Weight 93,94 
Group-B streptococcus is considered a common 
infectious cause of stillbirth, mostly in developed 
countries.  
Escherichia coli Stillbirth 24,92,97–99 
Preterm Birth 100–102 
Low birth weight 102 
E. coli is considered a common microorganism found 
in stillbirth tissue.  
Plasmodium falciparum, Plasmodium vivax Stillbirth 30,67 
Preterm birth 30,67,68,103–106  
Low birth weight 30,67–69,104–108 
Although stillbirth and prematurity, especially in 
primigravidae, have been associated with malaria in 
endemic areas, birth weight reduction is the main 
outcome described.  
 
Toxoplasmosis gondii Stillbirth 109–112 
Preterm Birth 113 
It is no longer a health problem in developed 
countries, but the real impact of this disease on 
negative pregnancy outcomes in low income 
countries is unknown.  
Human papilloma virus Preterm birth 114–116 HPV infection is likely to result in placental damage 
leading to preterm birth. Studies that show an 
association between this infection and other negative 
outcomes have not been found. 
Cytomegalovirus Stillbirth 117–119 
Preterm birth 57,119 
Low Birth weight 56,120 
 
Exposure to Cytomegalovirus may be associated with 
stillbirth, preterm birth as well as fetal growth 
restriction.  
Human Immunodeficiency Virus  Stillbirth 121,122 
Preterm birth 38,121,123–125  
Although stillbirth has been associated with HIV, the 
risk of HIV probably causing fetal death is not due to 
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Low birth weight 55,121,122,124–128 
 
 
the direct action of the virus but the depletion of 
maternal health. In addition, this virus can be 
associated with other diseases. 
Parvovirus (B19) Stillbirth 34,36,118,129 
 
Common viral cause of stillbirth, with a pathological 
mechanism which is well described in the literature. 
There are no studies showing an association with 
other adverse fetal outcomes.  
Herpes simplex virus Stillbirth 118,130  
Preterm birth 57,130,131 
Low birth weight 130 
Even when asymptomatic, untreated herpes has been 
associated with prematurity. However, the 
relationship of this virus with stillbirth and low birth 
weight needs to be further investigated. 
Measles   Stillbirth 132,133 Gestational measles has been described as a cause of 
stillbirth historically.  
Ebola  Stillbirth 40,134 Limited data suggest poor fetal and neonatal 
outcomes in pregnant women with Ebola.  
Zika  Stillbirth 135  
Intrauterine growth restriction 70 
The causal link between maternal Zika and congenital 
anomalies has been established with the evidence 
provided by innumerous studies after the 2015/2016 
epidemic. However, the association with other 
pregnancy outcomes needs to be better investigated. 
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Chapter 2. Literature review on dengue in general and dengue during pregnancy 
together with a systematic review on fetal outcomes. Dengue during pregnancy and 
adverse fetal outcomes a systematic review and meta-analysis (paper 1).      
 
Overview   
 In the first chapter, I discussed the general perspective of adverse 
outcomes of maternal infection and concluded that especially for viral maternal infection 
the literature is sparse. This chapter contains a literature review on dengue, the clinical 
manifestation of dengue when acquired during pregnancy, transmission rates and finally 
a systematic review on negative fetal outcomes, conducted in 2015 and published in 2016. 
By the end of this chapter, it is hoped to have established a general idea of the published 
evidence on adverse outcomes of maternal dengue infection when this study was initiated.         
In the following paragraphs, I will inform the importance of dengue in the public 
health arena. Then, I briefly describe the most relevant aspects of the disease in order to 
provide enough information on the general aspects to maximize the readers understanding 
of the importance, mechanisms and potential solutions for dealing with dengue during 
pregnancy.  
 
Dengue overview  
Dengue is the most common viral vector borne disease worldwide. It is estimated 
that annually 390 million people are infected of which 96 million develop clinical 
symptoms 136, 500,000 are hospitalized and 2.5% of these die 137. Dengue is endemic in 
at least 128 countries mostly in South America and Southeast Asia. The disease is 
spreading to new areas, include Europe, where outbreaks have been reported in more than 
10 countries since 2010 137.  
 There are four serotypes of dengue virus (DENV1, DENV2, DENV3, DENV4), 
infections with one serotype provides long immunity against that particular serotype; 
30 
 
cross immunity to the others is temporary 138. Infection by any serotype can cause dengue; 
co-circulation of four serotypes in the same place for many years generates a complex of 
antibody-mediated occurrences, such as protection and infection enhancement 139. The 
risk of severe dengue increases in subsequent infections, the mechanism that converts 
mild self-limited dengue to vascular permeability syndrome (DVPS) can be trigged by an 
immunopathological phenomenon infection of monocytes or macrophages, called 
antibody-dependent infection enhancement (ADE), which suppresses innate antiviral 
system, allowing logarithmic intracellular growth of dengue virus. Therefore, when 
individuals are infected in absence of cross-protective dengue antibodies, the dengue 
vascular permeability may ensue; this is the underlying pathophysiological mechanism 
of dengue haemorrhagic fever (DHF) /dengue shock syndrome (DSS) 140.  
 Dengue infection can be asymptomatic or lead to a range of clinical symptoms 139. 
Most cases of dengue are self-limiting and characterised by fever, headache, retroocular 
pain, myalgia, nausea, vomiting, and a rash (dengue fever –DF):  some cases progress to 
severe illness,  DHF or DSS characterized by the rapid onset of capillary leakage 
accompanied by thrombocytopenia and injury to the liver 141. The complex pathogenesis 
of dengue disease is not completely clear, thus it is not known how to predict who will 
develop the severe form of the disease, but some risk factors such as age, ethnicity, 
immune system of the host, presence of chronic diseases, viral characteristics, sequential 
infections, among others, have been described 142–145.   
 There is a live attenuated tetravalent vaccine licensed in 2015 and approved in 19 
countries initially recommended only in settings with a high disease burden 146. After 
licensed a mass vaccination effort were launched in Philippines and Brazil, targeting 1 
million people. However, the reassessment of data from the clinical trials showed an 
increase risk of severe dengue in vaccinated individuals seronegative before 
immunization compared with unvaccinated controls, therefore the WHO is no longer 
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indicating the use of this vaccine 147.  Antiviral drugs are ineffective. Treatment is 
symptomatic and is designed to treat the clinical manifestations and other conditions with 
emphasis on fluid replacement therapy and management of bleeding complications 141,148. 
Epidemiology and transmission  
During the 19th century, dengue outbreaks occurred sporadically. Only 9 
countries had reported cases of the disease in 1950s, however, the average number of 
cases notified to World Health Organization increased from 908 in 1950-1959 to 514.139 
in 1990-1999 149, reaching 3.2 million in 2015 137. These numbers are based on the passive 
detection of symptomatic cases and underestimate the true burden of the disease. Studies 
calculate that national surveillance systems report 2-28 fold fewer dengue cases than 
those that actually occurred 150,151. Mathematical modelling estimated that in 2013 the 
incidence of symptomatic cases was more than 58 million resulting in about 10000 deaths 
worldwide 152. The case-fatality rate is about 1% in most endemic areas (with a range of 
less than 1% -5%) 141,153.     
The geographical areas in which dengue has circulated have expanded in the past 
decade, and now four serotypes are circulating in the tropical area of Southeast Asia, 
Latin America and the Pacific and across Africa. Although more than 70% of the 
population at risk of dengue live in southeast Asia and Western Pacific region, the number 
of cases and deaths in Latin America have increased considerably and outbreaks have 
been reported in the USA and southern Europe (autochthonous cases in France, Croatia, 
Madeira and Italy) 137,154. Dengue has occurred mainly in urban areas, however, since 
2000 rural outbreaks have become more common 155. Dengue occurs among all age 
groups, in Southeast Asia there is evidence of an increase in the disease burden towards 
older age groups 156 and in America the available data on severity by age distribution are 
inconsistent 157. Both sexes were equally affected 157 (Figure 1).  
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Figure 1. Countries/areas at risk of dengue transmission, 2008.  
 
Source: World Helath Organization 
 
Dengue epidemiology is dependent on the ecology of the vector, so transmission 
has distinct patterns that are seasonal and cyclical reflecting factors that influence the 
dynamics of transmission 158.  The virus infects the mosquito during a blood meal of a 
viremic individual and after the extrinsic incubation period, the virus can be transmitted 
to another human via mosquito bites. Aedes aegypti and A. albopictus are the main vectors 
of the disease. A. aegypti is the most capable vector as it is highly adapted to the urban 
environment entering homes and breeding in small pools of water, such as plastic cups 
and bottles. It feeds primarily on humans, frequently biting several times in a single meal 
with an almost imperceptible bite 159.  A. albopictus has a wider geographical distribution 
and can be found in subtropical and temperate climates. Resilient and aggressive, this 
mosquito can survive in rural and urban areas and is relatively long lived (4-9 weeks) and 
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more able to survive through winter 160, potentially helping to expand dengue infections 
to new areas, father from equator 161.  The most common mode of dengue transmission is 
vector transmission., but non vector arboviruses transmission has been reported from 
vertical transmission 162, blood transfusion 163, tissue or organ transplantation 164 and 
nosocomial 165.    
Clinical manifestations  
 Dengue infection may be asymptomatic or lead to a spectrum of clinical 
presentations that can even result in death 138. Symptoms usually begin 5-7 days after a 
bite from an infected mosquito 166. Typically, signs and symptoms of a mild dengue 
presentation are non-specific and include self-limited febrile illness characterised by a 
headache, retroocular pain, myalgia, nausea, vomiting, and a rash 167. Most dengue 
infections are asymptomatic or mild. Generally one in four infections is symptomatic and 
commonly result in complete recovery, however, the ratio of asymptomatic to apparent 
infections varies and depends on age, virus serotype, previous infection with dengue and 
population background 168.  
During the febrile phase it is not possible to predict which small proportion of 
dengue cases patients will progress to more severe cases with symptoms such as systemic 
vascular leak syndrome, evidenced by growing hemoconcentration, hypoproteinemia, 
pleural effusions, and ascites, denominated dengue haemorrhagic fever (DHF). 
Compensatory mechanisms are up-regulated to maintain adequate circulation to crucial 
organs, narrowing the pulse pressure when loss of plasma becomes critical, dengue shock 
syndrome (DSS) occurs 169.  This progression from febrile phase to critical phase 
normally occurs between 4-7 days of the illness and it is critical for physicians to monitor 
warning sings such as persistent vomiting, abdominal pain, tender hepatomegaly, a high 
or increasing haematocrit level which is concurrent with a rapid decrease in the platelet 
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count, mucosal bleeding, and lethargy or restlessness 141. Atypical forms with severe 
hepatitis myocarditis and encephalopathy, among others, are being seen more often in 
endemic areas 170. These states of altered vascular permeability are short and revert to a 
normal level after about 48-72 hours with recovery of the patient’s symptoms 169.  
General aspects of diagnosis, treatment and prevention 
 The clinical feature of dengue is unspecific and is therefore similar to other non-
dengue febrile illnesses making clinical diagnosis difficult without laboratory tests. 
However, any definitive diagnosis needs sophisticated examinations that are difficult and 
expensive to implement in many endemic areas 171.  
 The appropriate laboratory test for dengue depends on the timing of the sample 
collection. Virus isolation is the most specific test; however, virus culture is not easily 
available and maintanable. During the viremic phase, on average 5 days after the onset of 
symptoms, it is possible to detect the virus nucleic acid in serum by reverse-transcriptase–
polymerase-chain-reaction (RT-PCR) 172 or identify the virus non-structural protein 
(NS1). Because viremia decreases in a very short period of time, a negative RT-PCR does 
not rule out the suspected diagnosis; serological testing should be performed.   
 Seroconversion IgM or IgG is frequently used in suspected dengue cases. The 
presence of IgM or high levels of IgG in acute serum suggests a probable infection 173.  
However, due to strong cross reactivity a positive IgM test only indicates a recent 
flavivirus infection 146.  
Plaque-reduction neutralization tests (PRNT) can be used as an alternative test. It 
can measure virus-specific neutralizing antibodies and may be able to determine the cause 
of the primary infection with high specificity 166. However, in previously infected or 
vaccinated patients cross-reactions may make it difficult to identify which flavivirus is 
causing the patient’s current infection 172. Serological test interpretation is complex and 
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should be carried out carefully, a positive test could be a result of cross-reaction and 
PRNT may be able to discriminate only in primary infections. A negative IgM test result 
obtained 2-12 weeks after travel suggests that infection did not occur 172 (Table 1). 
 
Table 1: Dengue diagnostics and sample characteristics  
 Clinical 
sample 
Diagnostic method Methodology Time to 
results 
Virus detection 
and its 
components 
Acute serum 
(1-5 days of 
fever) and 
necropsy 
tissus 
 
Viral isolation Mosquito or mosquito 
cell culture inoculation 
One week or 
more 
Nucleic acid 
retection 
RT-PCR and real time 
RT-PCR 
1 or 2 days 
Antigen detection NS1 Ag rapid tests Minutes 
NS1 Ag ELISA 1 day 
Immuno-
histochemistry 
2-5 days 
Serological 
response 
Paired sera 
(acute serum 
from 1–5 days 
and second 
serum 15–21 
days after) 
 
IgM or IgG 
seroconvesion 
ELISA 
HIA (haemagglutiation 
inhibition essay) 
1-2 days 
Neutralization Test Minimum 7 
days 
Serum after 
day 5 of fever 
IgM detection 
(recent infection) 
ELISA 1 or 2 days 
Rapid Tests Minustes 
IgG detection IgG ELISA 
HIA 
1 or 2 days 
Source: World Health Organization 
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There is no effective antiviral drug available to treat dengue patients, so the 
management of the cases is supportive, with particular emphasis on fluid therapy and 
careful monitoring of warning symptoms 169,173. Patients without complications require 
oral fluids to compensate for fluid loss. With the earliest threat of severe disease, a 
parenteral line should be used to provide fluids and avoid haemodynamic instability and 
hypotension. Early fluids restauration can prevent other complications and restore the 
plasma volume  138,169,173.        
Until very recently, the only approach available to control or prevent dengue 
transmission was vector control. However, the results of this have been very 
disappointing and vector-control programs have not prevented the spread of dengue 
174,175. 
Since 2016, a dengue vaccine (CYD-TDV) has been approved in 19 countries,   
176. This is a live attenuated tetravalent vaccine that has shown efficacy against 
virologically confirmed symptomatic dengue of 61% (95% CI 52-68) for any serotype 
and lower efficacy for DENV 1 and 2 (50% and 39% respectively) when evaluated in 2 
parallel Phase 3 randomized clinical trials 146,177. There are also  safety concerns due to 
the increased risk of hospitalization and severe dengue identified in the 2-5 years old ages 
group. As a result, the vaccine is only recommended for children over 9 years old176. 
Another concern about this vaccine is that regardless the age at vaccination, there was an 
increased risk of severe dengue in vaccinated individuals seronegative before 
immunization compared with unvaccinated controls 147. After the release of these new 
analyses, the WHO changed the recommendation from highly endemic regions to 
individual with proven past dengue infection. At this moment there are two more vaccines 
(Takeda TDV and another one from Butantan) that will finish the data collection of the 
phase 3 trial later this year 147.  
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Risk of acquisition and clinical manifestation in pregnant women 
 Most studies have shown a high seroprevalence rate of dengue among parturient 
of over 90% in endemic countries such as Brazil and Thailand 162,178–181. In Malaysia the 
seropositivity rate was much lower, approximately 36% 182. Advanced maternal age has 
been positively associated with seropositivity, indicating that younger women are at more 
risk of acquiring dengue during pregnancy while older pregnant women were more likely 
to have protective immunity 178,182.      
 It is difficult to know the exact incidence of dengue infections during pregnancy, 
because physiological changes such as hemodilution that occur during pregnancy can 
mask thrombocytopenia, leucopoenia, or hemoconcentration and common obstetric 
problems can cause haematological and hepatic issues. This may result in difficulty in 
differentiating DHF from conditions such as HELLP syndrome leading to misdiagnosis 
183,184. The incidence of dengue-specific IgM in pregnant women (indication of recent 
infection within the last 6 months) has been around 2.5% in most studies, ranging from 
0.7% in Sudan in Africa 185 to 10% in Northeast Brazil 179. Variation in the incidence rate 
of dengue can occur within the same country, for example in Brazil serological evidence 
of recent dengue was found in 2.8% of parturient in the Midwest 186 and 10% in the 
Northeast 179. 
There is some evidence that dengue during pregnancy is associated with a more 
severe presentation when compared with non-pregnant women. A publication using data 
from the Brazilian surveillance system showed that the risk of severe dengue was 
threefold higher among pregnant women compared to non-pregnant women. 
Hospitalization and mortality among pregnant women were more frequent relative to non-
pregnant women 187. In Sri Lanka, among pregnant women, DHF was present in 56% of 
the patients after primary infection 188, while in another cohort of non-pregnant 
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hospitalized adults in the same country, only 24% developed DHF followed a primary 
infection 189. There is preliminary  evidence that there is a high risk of severe dengue in 
the second and third trimester 187,188,190, however, it should be better investigated. Atypical 
presentations, although rare, have been reported such as cardiac 191 and encephalic 192 
effects.     
Dengue during pregnancy has been related with poor maternal outcomes; 
however, it is difficult to estimate the burden of this illness in this population since most 
of the studies are case series, so it is difficult to state if the values would be higher or 
lower than expected in the area where the study was conducted. Some studies have 
reported maternal deaths in women with dengue, such as Adam et al (2010) who reported 
maternal clinical complications which occurred among dengue infected patients, 6.4% 
had vaginal bleeding and 10% delivered by caesarean section. Maternal hemorrhage and 
difficulties in maintaining hemostasis during caesarian were also observed 193. In a study 
with 53 pregnant women exposed to dengue, the maternal case-fatality was 1.9%, 22% 
delivered by cesarean and 10% had hemorrhage at birth 184. Among 62 pregnant women 
with dengue in India, 15% developed severe dengue all in the third trimester 190. Two 
cohorts comparing pregnant women exposed and unexposed to dengue in Brazil and 
Colombia found more maternal deaths among the dengue exposed group 194,195. However, 
both studies had small numbers, only one maternal death occurred in the Colombian 
cohort and two in the Brazilian.   
Intrauterine transmission rates 
 The dengue specific seroprevalence of IgG antibodies transferred at delivery is 
high, frequently over 90% in endemic regions 179,181,186, however, cases of vertical 
transmission are more rarely described at literature. The placenta is protective to the fetus 
though it is not always consistent or complete and increased vascular permeability and 
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endothelial damage in DHF may cause disruption of the placental barrier contributing 
towards vertical transmission of dengue 196,197. Once the virus reaches the placental tissue, 
pathological changes can be produced such as villous stromal edema, increases in the 
formation of syncytial knots and chorangiosis, resulting in hypoxia 198,199. The hypoxia 
itself could cause stillbirth, however. in most vertically transmitted dengue cases the 
newborn survived without sequelae 184,197.  
The rate of vertical transmission varies, ranging from not observed to 15% 179,184. 
Apparently, vertical transmission is more likely to happen when dengue is clinically 
apparent and this depends on maternal severity and gestational age. All cases of 
congenital dengue have occurred in neonates born to mothers infected late in pregnancy, 
mainly when the symptoms occur at the time of delivery. In Malaysia, a study showed a 
vertical transmission rate of 1.6%, however, 89% of the women who were dengue IgM-
positive did not report symptoms 162. Studies that only included clinically apparent 
dengue in pregnant women seem to report a higher number of neonates who are vertically 
infected (6.8% in Cuba 200 and 15.% in French Guiana) 184. However, this is not always 
true and a study from India of eight pregnancies with symptoms of dengue 183 and in 
another one among 16 parturient that reported fever in Brazil, no case of vertical 
transmission was identified 179.     
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Thesis rationale 
Dengue stands out from others viral mosquito borne disease because it is the most 
common; its incidence is growing and it is reaching new geographical areas and spreading 
worldwide. Indeed, reported cases of negative pregnancy outcomes after dengue infection 
are not new; however, the evidence of the association between maternal dengue and 
adverse pregnancy outcomes is limited, controversial and mostly supported by cases 
reports. The studies published until I start this thesis were: 1) mostly cases series, without 
a comparison group; 2) those with comparison group were hospital based, therefore only 
capable of capturing the most severe cases; 3) they did not have enough number to study 
less frequent outcomes (such as stillbirth or maternal deaths) or categorize the exposure 
by severity; 4) most of them did not control for confounders.  There is a lack of population 
based studies that could estimate the magnitude of the risk (if proved), appropriately 
controlled by confounding and with enough number of observation to study rare outcomes 
and categorize the exposure (dengue) by severity of the maternal disease.  
To be able to fill this gap in the literature I will use routine collected data from 
Brazil (a country where detailed, high quality data are captured and dengue is endemic). 
These population-level longitudinal data have the information required to expand the 
existing knowledge on birth outcomes from women with dengue acquired during 
pregnancy and they have sufficient number and less attrition than set up an ordinary 
community based cohort.  
In this thesis, I will contribute to the debate on 1) infectious disease occurring 
during pregnancy: this information would enable physicians to be able to properly 
conduct a risk assessment in pregnant patients and for policy maker to use these 
information to support the inclusion of this group in at risk population. 2) Use of 
secondary data in epidemiological studies: the recent availability of administrative data 
52 
 
for research provides new opportunities for creating informative datasets to help us to 
answer research questions that require large numbers and it is difficult to set up an 
ordinary cohort due to expensive cost and potential loss of follow up.       
Thesis aims and objective  
 The aim of this thesis is to explore the relationship between pregnancy outcome 
and symptomatic maternal dengue.  
 The aim of the thesis was achieved by completing the following objectives:  
1. To develop a specific linkage algorithm and apply in a large administrative 
databases from low-middle income country: 
a.  I extracted data from Brazilian databases on pregnancy outcomes and 
dengue notification; 
b. I used common variable between the datasets (name of the mother, age 
and place of residency) and calculated match weight;  
c. I applied the specific created algorithm to link the dengue and birth and 
maternal deaths records.     
2. To describe and evaluate the linkage and discuss potential bias associated with the 
linkage process. I conducted this step to ensure valid results, showing that the 
linkage did not affect the measure of association in the next step 
a.  I created a gold standard to compare its results with the results obtained 
by our algorithm;  
b.  I compared the accuracy of our algorithm with a widely used software for 
linking data in Brazil.  
3. To estimate the association between dengue and adverse pregnancy outcomes:  
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a.  I analysed the data obtained after the linkage process; focus on three main 
outcomes: stillbirth, births outcomes (preterm birth, low birth weight and 
small for gestational age) and maternal deaths.  
Thesis overview  
 There are four section, 9 chapters and 6 papers in this thesis (Figure 2). The first 
section contains the chapter one and two. Together they provide a background to the 
thesis. They discuss issues arising the nature of the current knowledge about adverse 
outcomes of maternal infections, such as the lack of evidence on viral maternal infection 
when compared with bacterial infections. I then contrast with the importance of dengue 
worldwide and the lack of evidence about its effects during pregnancy. The final section 
of chapter 2 is a systematic review on adverse fetal outcomes of maternal dengue 
infection.   
The second section contains chapter three to five, these chapters describe the data 
source, analyses and the linkage process, providing detailed information on Brazilian 
Information System (data source), and the evaluation and validation of the linkage 
process.     
The third section comprises the results chapters formatted as three papers. Each 
of them includes an introduction, methods, results and discussion, as well as tables and 
figures which is referred thought the paper. Any other relevant information is included in 
the chapter introduction. Then the thesis is concluded with a final discussion and 
recommendations for public health policies and future areas of research.       
It is important to highlight that each paper was written as a separate article, and 
as such, there is some repetition of information. I have endeavoured to keep terminology 
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consistent throughout the papers, but due to variation in journal specifications and in the 
published literature, differences in terminology may exist.  
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Figure 2: Aim of the thesis with corresponding objectives, sections, chapters and papers.   
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Methods Section  
Overview 
The overall aim of this thesis is to examine the relationship between adverse 
pregnancy outcomes and symptomatic maternal dengue. To accomplish this, I used 
administrative collected data. Firstly, this was mainly because of its availability in the 
country where the research was conducted and secondly to answer this specific research 
questions, due to the rarity of the outcomes and exposure, would require establishing a 
cohort with large numbers of pregnant women. To set up an ordinary cohort would be 
expensive and they have been proven inefficient in other research to achieve sufficient 
sample size to analyse rare outcomes (such as stillbirth) or to do sensitivity analyses, for 
disease severity for example. Therefore, the use of administrative collected data is a 
cheaper yet efficient alternative.   
The data available in Brazil have the information on exposure (dengue) and 
outcome (pregnancy outcomes), however they are recorded in different databases and not 
routinely linked together or have a unique identifier available. Therefore, in order to 
assess the exposure (dengue during pregnancy) the method of choice for linkage is to 
calculate the probabilistic match weight that measures the similarity between records 
from different datasets, taking into account errors in the identifier and missing data. 
Linkage between data without unique identifier relies on calculate probabilistic match 
weights that measure the similarity between records from different sources, with 
considerable potential for misclassification (errors in the linkage- records not correct 
match or a match that did not exceeds the used threshold). Even a slight linkage error can 
produce substantial bias in the final analyses, especially if the data belonged to a particular 
group, e.g. less educated women or the youngest ones 1. As a result, providing information 
on data quality and evaluating the linkage is a crucial step in this thesis as well as 
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understanding the extent of linkage error and potential impact on the analysis of the 
results.   
The methods section contains three chapters and two papers, altogether this should 
inform the readers of the quality of the data used and the quality of the performed linkage 
process. In the third thesis chapter (first chapter of the methods section), I describe the 
country where the study was conducted and the details of the administrative data. 
Information on the data collection and processing are included for each of the datasets 
and finally I summarize the analytical methods performed to calculate the association 
between dengue during pregnancy and adverse maternal and fetal outcomes.  
The following chapters are two papers that describe in detail the complete linkage 
process and its evaluation. The fourth chapter (second paper of the thesis) describes the 
linkage between stillbirths and dengue cases, evaluates the linkage accuracy, discusses 
potential bias and its potential effects on the final analyses. At the end of this chapter, I 
include supplementary information on live births linkage.  
The fifth chapter (paper number three) evaluates the linkage between records of 
maternal deaths and dengue cases. Although this paper describes a linkage process using 
similar techniques as applied in the paper described in chapter four, some unique factors 
are applied and will be described in detail in this thesis chapter. This chapter also includes 
information on linkage accuracy, linkage error and its effects on the final analyses.     
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Chapter 3. Description of study area and design, data source and statistical analysis  
Study design  
This thesis used large population-based health datasets by linking routine records 
of birth outcomes and maternal deaths with records of women notified and confirmed 
with dengue disease in Brazil from January 1, 2006 until December 31, 2012. I used this 
period because Chikungunya and Zika arrived in Brazil in 2014/2015, so dengue had been 
the most important vector borne disease circulating in the country during the study period.      
It is important to highlight (as a paper style thesis) that each paper was an 
independent study; as a result, there was some variation in study design and study period. 
Specific information is included in the methods section of each paper.  
Study Area 
The study area is Brazil, a South American country with more than 200 million 
inhabitants. According to national data, almost 3 million births and more than 30 thousand 
stillbirth are registered per year, prematurity and low birth weight rates were 10.8% and 
8.4% in 20152.  
 Dengue control in Brazil is considered a failure because since 1986 the incidence 
and the number of severe cases have increased 3. All four serotypes are circulating 
throughout the country. From 2001 to 2012 more than 5.5 million cases were notified to 
the Brazilian Ministry of Health, 55% of them in women 4.  
Brazil has a long tradition of collecting administrative data and its quality is 
constantly improving. There is a large body of research evaluating the quality of routinely 
produced electronic data as well as substantive health research conducted using these data 
5–7. 
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Data source – Brazilian Information System 
This thesis used routine data from the Information System of Brazil. This system 
records health data in the country, including births, dengue cases and deaths. I will 
describe each of them in detail below:   
a) SINASC (Sistema de Informação sobre Nascidos Vivos/ Live 
Birth Information System) 
This system is updated using the registration of a live birth. This is a legal 
document, created in 1990 and used throughout the country. The forms are pre numbered 
and in three copies identified by colours (white- the form kept by the local health council 
that digitizes the information and sends it to the Brazilian Information System 
headquarters; yellow- kept by the local registry office that generates a birth certificate; 
pink- kept in the health records of the pregnant women or neonate in the facility). This 
document has to be completed by a health professional who was present at the delivery.  
This form is divided in eight blocks (appendix III). I -characteristics of the 
newborn: sex; Apgar score in the 1 and 5 minute, birth weight (the child should be 
weighed in the first five hours of life), presence of abnormality. II- identification of the 
place of birth: home, centre or hospital birth and includes the address of the place. III- 
characteristics of the mother: name, age, marital status, education, race, place of 
residence. IV- identification of the father: name and age of the father (this is a new block 
introduced after 2011). V- characteristics of pregnancy and delivery: previous pregnancy- 
there is information on the number of previous pregnancies of live births, stillbirth or 
abortion; about the current pregnancy- there is information on the length of gestation 
(estimated from the day of the last period), type of delivery, number of fetus, number of 
visits to prenatal care facilities, which health professionals were present at the delivery. 
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VI- characteristics of congenital anomalies: this block should be filled in when congenital 
anomalies are identified at birth using the ICD-10 code. VII- identification of the 
professional completing the notification. VIII- registry office identification (Table 1) 8.  
 
Table 1: Information available on SINASC 
Blocks  Contents  
I -characteristics of the 
newborn 
Sex; Apgar score in the 1 and 5 minute, birth weight, presence of 
abnormality 
II- identification of the 
place of birth 
Home, centre or hospital birth and includes the address of the place 
III- characteristics of the 
mother 
Name, age, marital status, education, race, place of residence 
IV- identification of the 
father 
Name and age of the father 
V- characteristics of 
pregnancy and delivery 
Previous pregnancy- number of previous pregnancies of live births, 
stillbirth or abortion;  
Current pregnancy- length of gestation, type of delivery, number of fetus, 
number of visits to prenatal care facilities, which health professionals were 
present at the delivery. 
VI- characteristics of 
congenital anomalies
  
Congenital anomalies identified at birth using the ICD-10 code 
VII- identification of the 
professional 
 
VIII- registry office 
identification 
 
 
The Ministry of Health of Brazil uses the WHO definition of a live birth (Table 
2) 9:   
The complete expulsion or extraction from the body of the pregnant woman of 
a product of conception, independent of the duration of pregnancy, who, after 
the separation, breathes or shows any other signs of life, such as heartbeat, 
umbilical cord pulsation, or definite movement of voluntary muscles, whether 
or not the cord is cut and whether or not the placenta is attached.  
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Table 2: Brazilian Ministry of Health definition of the terms  
Term  Definition  
Live birth  The complete expulsion or extraction from the 
body of the pregnant woman of a product of 
conception, independent of the duration of 
pregnancy, who, after the separation, breathes or 
shows any other signs of life, such as heartbeat, 
umbilical cord pulsation, or definite movement of 
voluntary muscles, whether or not the cord is cut 
and whether or not the placenta is attached 
Stillbirth  Stillbirth is the death of a product of conception 
before the expulsion or complete extraction from 
the body of the pregnant woman, occurring after 20 
week of pregnancy or 154 days or fetus weighing 
more than 500 g. The fetus, must not after the 
separation, breathe or show any other sign of life, 
such as heartbeat, umbilical cord pulsation, or 
definite movement of voluntary muscles.  
 
Maternal deaths  Maternal death is the death of a woman while 
pregnant or within 42 days of termination of 
pregnancy, irrespective of the duration and site of 
the pregnancy, from any cause related to or 
aggravated by the pregnancy or its management 
but not from accidental or incidental causes 
 
Most of the studies using SINASC show that the coverage rates of the system in the 
coutry is higher than 90% 10 varying from 85.7% to 100% between 1999 and 2011 5,11–14. 
Regarding the accuracy of the information recorded in SINASC, no routine evaluation is 
done 15, however, some studies have compared information from SINASC with 
information obtained from medical records or interviews with mothers. The results of 
these studies have shown that the birth weight registered in SINASC are similar, almost 
100%, to medical records data 16. However, the percentage of preterm births recorded in 
SINAN was found to be underestimated by 15% 16 17. The completeness of the data is 
very high, missing data do not exceed 10% in most of the variables, except the number 
of previous stillbirths or abortions experienced (19% in 2002 and 11.1% in 2010). 
b) SIM (Sistema de Informação de Mortalidade/ Mortality Information System). 
From this dataset, I retained information on stillbirths and maternal deaths. This 
system uses the death certificate, a legal document that can only be completed by a 
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physician 9. The forms are in three copies identified by colours (white- this form is kept 
by the local health council that digitizes the information and sends it to the Brazilian 
Information System headquarters; yellow- kept by the local registry office that generates 
a death certificate; pink- kept in the health records of the women) 18.   
This form is divided into nine blocks (appendix IV). I –identification: in this block 
first you notify if it is a fetal death and then provide information on date of death and 
birth, name of the dead individual, name of the mother and father, sex, race, marital status, 
occupation and education of the dead person; in the case of fetal death some of the 
variables will not be applicable. II- identification of the place of residence: complete 
address. III- identification of the place of death: hospital, home, public place and includes 
the address of the place. IV- characteristics of the mother: name, age, marital status, 
education, occupation, race, number of births, place of residence, length of gestation, 
number of previous stillbirths or abortions, type of delivery, number of fetus in the current 
pregnancy, birth weight (this block should be filled only in the case of fetal deaths or 
infant mortality). V- cause of death: identify the cause of death using ICD-10 code. VI- 
identification of the professional completing the notification. VII- identification of violent 
deaths. VIII- registry office identification. IX - This block must be filled in when the 
death occurred in a place without a medical doctor (Table 3)18.         
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Table 3: Information available on SIM  
Blocks  Contents  
I –identification Notify if it is a fetal death, date of death and birth, name of the dead 
individual, name of the mother and father, sex, race, marital status, 
occupation and education of the dead person; in the case of fetal death 
some of the variables will not be applicable. 
II- identification of the place 
of residence 
Complete address 
III- identification of the place 
of death 
Hospital, home, public place and includes the address of the place 
IV- characteristics of the 
mother 
Name, age, marital status, education, occupation, race, number of 
births, place of residence, length of gestation, number of previous 
stillbirths or abortions, type of delivery, number of fetus in the current 
pregnancy, birth weight (this block should be filled only in the case of 
fetal deaths or infant mortality) 
V- cause of death Cause of death using ICD-10 code 
VI- identification of the 
professional completing the 
notification 
 
VII- identification of violent 
deaths 
 
VIII- registry office 
identification 
 
IX - This block must be filled 
in when the death occurred in 
a place without a medical 
doctor 
 
 
The Brazilian Ministry of Health uses the WHO definition of stillbirth (Table 2) 19:  
Stillbirth is the death of a product of conception before the expulsion or 
complete extraction from the body of the pregnant woman, occurring after 22 
week of pregnancy or 154 days or fetus weighing more than 500 g. The fetus, 
must not after the separation, breathe or show any other sign of life, such as 
heartbeat, umbilical cord pulsation, or definite movement of voluntary muscles.  
 
 Although Brazil uses the WHO definition, in which the gestational age limit is 22 
weeks, the doctor can fill a death certificate when the stillbirth occurs from 20 weeks 18.    
The Ministry of Health of Brazil uses the WHO definition of maternal deaths 
(Table 2): 
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Maternal death is the death of a woman while pregnant or within 42 days of 
termination of pregnancy, irrespective of the duration and site of the pregnancy, 
from any cause related to or aggravated by the pregnancy or its management but 
not from accidental or incidental causes.  
 In Brazil, for investigation purposes, maternal death is considered the death of a 
woman while pregnant or up to a year of termination of pregnancy, irrespective of the 
duration and site of the pregnancy, from any cause related to or aggravated by the 
pregnancy or its management but not from accidental or incidental causes. However, the 
Ministry of Health calculates the official estimates using the 42 days definition.   
  In this thesis, I only used maternal deaths coded under the chapter XV (pregnancy, 
childbirth and puerperium) of the ICD-10 using the one year rule, because there was not 
enough information to classify whether deaths due to diseases coded under different 
chapters could be a maternal death (Table 4). 
Table 4: International classification of disease-10 chapter XV (pregnancy, childbirth and 
puerperium) 
Code  Group  
O00-O08 Pregnancy with abortive outcome  
O10-O16 Edema, proteinuria and hypertensive disorders in 
pregnancy, childbirth and puerperium 
O20-O29 Other maternal disorders predominantly related to 
pregnancy  
O30-O48 Maternal care related to the fetus and amniotic 
cavity and possible problems  
O60-O75 Complications of labour and delivery  
O80-O84 Delivery  
O85-O92 Complications predominantly related to 
puerperium  
O95-099 Other obstetric conditions  
 
 
The completeness of the variables from SIM database differs among stillbirths 
and non-stillbirths. For stillbirths there is a high frequency of missing variables, the lack 
of data varies according to variables and exceeded 15% for most of the variables, except 
maternal education, which was more than 25% in 2010. The completeness of maternal 
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deaths information is very high. In our data, completeness of the variables of interest was 
higher than 95%.  
 
c) SINAN (Sistema de Informação sobre Agravos de Notificação/ Information 
System for Notifiable Diseases)   
From this database, information on women who were notified and confirmed as a 
dengue cases was retained (appendix V). In Brazil compulsory notification of cases of 
dengue is required since 1998, in accordance with Ordinance No 1,271/2014. Suspected 
and/or confirmed cases must be reported to the Epidemiological Surveillance service on 
a specific numerated notification form (appendix V), which is available in any local health 
facility. This form can be filled in by any health professional who suspects dengue. It 
collects information on date of notification, date of onset of symptoms, date of birth, name 
of the patient, age, sex, and address. 
The Epidemiological Surveillance Centre 20 then investigates to confirm or 
discard the suspicion based on the Brazilian definition of clinical epidemiological cases 
and/or laboratory results. The Brazilian definition of clinical epidemiological cases of 
dengue is the presence of fever and two or more of the following, retro-orbital or ocular 
pain, headache, rash, myalgia, arthralgia, leukopenia, or haemorrhagic manifestations. In 
addition to these symptoms, the patient must have been in areas where dengue is being 
transmitted or where Aedes is present 21 in the past fifteen days. Laboratory confirmed 
cases are those with the presence of clinical symptoms and a positive test that could be 
IgM antibodies detection by enzyme-linked immunosorbent assay (ELISA), viral 
Ribonucleic acid (RNA) detection via Polymerase chain reaction (PCR), Nonstructural 
protein 1 (NS1) viral antigen detection, or positive viral culture. Suspected cases are 
discarded based on 1) negative laboratory test, especially IgM (once confirmed that the 
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sample was collected in the appropriate time, in dengue cases, IgM may remain elevated 
for two to three months); 2) does not have clinical-epidemiological link criteria, that is 
there is no way to establish the chain of transmission; 3) laboratory confirmation for 
another disease; 4) case without laboratory confirmation and with signs and symptoms 
compatible with another pathology. The case must be closed (confirmed or discarded) 
within 60 days.     
After investigation, information on laboratory results and clinical progress of the 
case is collected and then, if confirmed, it can be classified into three clinical categories: 
“dengue fever” as a self-limiting disease (fever, with a severe headache, pain behind the 
eyes, muscle and joint pain, and rash), “complicated dengue”, and “dengue haemorrhagic 
fever/ dengue shock syndrome”. Complicated dengue is a Brazilian definition of severe 
cases of dengue that do not meet the WHO criteria for dengue haemorrhagic fever (fever, 
haemorrhagic evidence, thrombocytopenia and evidence of plasma leakage) and could 
not be classified as a mild self-limited disease due to its severity. Complicated dengue is 
used when a probable case of dengue presents one of the following: severe changes in the 
nervous system, cardiorespiratory dysfunction; insufficient hepatic function; 
gastrointestinal bleeding, cavity spills, or thrombocytopenia equal or less than 
50,000/mm3 leucometry less than 1000/mm. Dengue haemorrhagic fever follows the 
WHO criteria and is characterized by fever, haemorrhagic evidence, thrombocytopenia 
and evidence of plasma leakage.  
After 2009, the WHO changed the dengue classification into dengue fever (DF), 
dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) to non-severe 
(with and without warning signs) and severe. This new classification started to be 
implemented in Brazil in 2014, after the study period of this thesis.    
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Studies have shown that dengue surveillance substantially underestimates the 
disease burden, mainly during periods of low-transmission. It is estimated that there were 
12 cases of dengue per reported case in the community, however, during low dengue 
transmission the ratio can reach 17:122. The completeness of the data in the used variables 
were reasonable. Less than 0.05% of the records were excluded because the name of the 
patient was missing and 5% of the dengue cases did not have a final classification of 
severity of the case.   
Statistical analysis  
Specific information is included in the methods section of the papers. After 
concluding the linkage process, I used logistic regression to model the variables, as the 
study outcome is a dichotomous variable, including birth weight that was categorized as 
low birth weight and normal birth weight. In general, I estimated the crude and adjusted 
odds/risk ratios using logistic regression (conditional or not, depends on how the 
comparison group was selected). However, empty and small cells can make the model 
unstable; in this case, I applied the Firth method (to reduce the small sample bias in 
maximum likelihood estimation). The Firth method can be used to overcome the 
condition in which maximum likelihood estimation tends to infinity called separation. In 
this method, the coefficient of interest is constrained to zero and left in the model to allow 
its contribution to the penalization. The penalization allows convergence to finite 
estimates with very sparse data and over-corrects for bias 23.  
The variables used as confounders followed the criteria: available in good quality 
in the datasets; associated with the exposure; risk factor for the outcome and not in the 
causal pathway. The used confounders vary according to the outcome, but the full list are 
maternal age (categorized as <=20; between 20-35; >=35 years old), education (less than 
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3 years; between 4-7 years; more than 8 years) and marital status (single; widow;divorced 
or married or stable union) and mode of delivery (vaginal; caesarean section).   
A sensitivity analysis of the validity of clinical/epidemiologic diagnosis was 
carried out; I repeated the analyses using only laboratory confirmed dengue. This was 
because misclassification of dengue based on the lack of laboratory confirmation is 
possible. I investigated the effect of time between disease onset and maternal/ birth 
outcomes, since dengue is an acute disease, with few reports of chronicity. I would expect 
that the magnitude of the association would be higher in the first days of disease onset, 
since dengue is known as an acute disease. The time between disease onset and the 
outcome was calculated using the date of the disease onset (information available from 
SINAN) and the date when the outcome occurred (date of birth/death). Finally, I 
performed analyses for dengue severity (mild dengue, dengue with complications and 
dengue haemorrhagic fever). When necessary, the potential effects of missing data were 
also investigated, assuming that all missing data for confounding variables in the cases 
were in the low-risk groups and all missing data for the comparison group were in the 
high-risk groups.        
In one study, the population attributable fraction was calculated, (PAF; 
PAF=[p1(OR–1)] /OR) using the punafcc package in Stata, which uses a logistic 
regression method and provides PAF (and 95% CIs) with adjustment for confounding 
variables by combining adjusted ORs and the observed incidence of dengue among cases. 
For all the statistical analyses Stata version 14.1 software was used.  
The linkage procedures will be discussed in the following two chapters.  
  
88 
 
Chapter 4. Linkage procedures and evaluation- Description of the stillbirth and live 
birth linkage process 
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Evaluation of records linkage of two large administrative databases: live births and 
notifications of dengue   
Backgroud  
In the paper above, I presented and discussed the methods used in the linkage 
process and evaluated the quality of the linkage between dengue cases and stillbirth (SIM-
SINAN). The next linkage carried out was the linkage between dengue cases and live 
births (SINASC-SINAN). This linkage faced the same challenges as dengue and stillbirth 
linkage, such as the availability of well-completed identifiers, linkage of records 
belonging to different individuals and the unknown number of expected matches. Because 
of this, I implemented the same technique described in the paper above.  
Although I applied the same technique used for stillbirths and used the same 
variable in the linkage, there are two main reasons to explain the importance of 
conducting an evaluation of the quality of the linkage between live births and dengue. 
First, for any linkage it is important to incorporate information on linkage error into 
results. Second, to estimate the association between dengue and stillbirth and dengue and 
maternal deaths, live births is the control group. Therefore, I have to ensure the validity 
of the linkage to measure the exposure in a similar way for cases and controls. In other 
words, this is to guarantee that the linkage error is a non-differential error so that 
misclassification of dengue does not vary according to outcome (stillbirth or live birth). 
For example, if the sensitivity (true links among the matches) of the linkage were higher 
among stillbirth, the measure of association would be overestimated, and a false 
assumption about a positive relationship would be presented.       
 To link and evaluate the linkage between dengue notification and live births, the 
same technique described in the paper above was used. First data pre-processing, blocking 
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by municipality, the creation of a Gold-standard data and classification of the links.  I 
selected only two Brazilian states to work with in the linkage evaluation, because there 
are approximately 3 million live births in Brazil and limited time and resources for this 
project. In the data pre-processing step, my final study population comprised 23,190 
dengue notifications from SINAN and 180,438 live births from SINASC in two Brazilian 
states (Ceara and Espirito Santo) in 2010. The subsequent steps (blocking, gold standard, 
match calculation, classification of links and statistical analysis) were performed as 
described previously.   
Results  
Of the 23,190 eligible dengue cases in SINAN for 2010, 369 were linked to a live 
birth record using the nine-step gold-standard algorithm. The threshold was set to a match 
weight of 21.9, and resulted in 241 links. Comparison with the gold-standard identified 
11 false matches and 139 missed-matches, giving a sensitivity of 230/369=62% and a 
PPV of 230/241=95%. Linkage errors were not associated with any recorded study 
variable (Table 1). 
The threshold for uncertain links was defined as those with weights between 21.9-
17. Records with a match between these thresholds were classified through manually 
inspection to determine whether they belonged to the same person. This added 95 true 
links increasing the sensitivity to 88% and bringing the total number of linked records to 
325.     
Discussion  
 I applied the same method to both datasets (live births and stillbirth). As shown 
in the stillbirth linkage, the sensitivity was not very high, probably due to the lower 
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number of identifiers. However, when I compared the results obtained in both linkages 
the accuracy was similar. The stillbirth-dengue linkage presented a sensitivity of 64% and 
PPV of 93.9, the live birth-dengue linkage showed a sensitivity of 62% and PPV of 95%. 
Therefore, the linkage used as an instrument to assess the exposure in this study 
introduced error, (the sensitivity was around 60%). However, this error was independent 
of the outcome.  
 The analyses of linkage error were not associated with any maternal or birth 
characteristic (Table 1). These analyses showed that the missed matched was not 
associated with a specific group, so it is unlikely that the linkage process introduced bias 
in the analyses that will be carried out in the subsequent studies.   
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Table 1. Associations between linkage accuracy and characteristics of the cohort 
 
 
True matches  
N=230 
n (%) 
Missed-matches  
N=139 
n (%) 
p-value 
Age of /the mother in years    
<20 50 (21.7) 35 (25.2) 
p=0.668 
20-35 168 (73.0) 96 (69.1) 
>35 12 (5.2) 8 (5.8) 
Missing - - 
Maternal literacy     
Illiterate  3 (1.3) 1 (0.7) 
p=0.793 
1-3 years  13 (5.6) 6 (4.3) 
4-7 years 81 (35.2) 42 (30.2) 
>8years s 96 (41.7) 69 (49.6) 
>11 years 31 (13.5) 17 (12.2) 
Missing  6 (2.6) 4 (2.9) 
Maternal status    
Single/Widow/Divorced  155 (67.4) 91 (65.5) 
p=0.912 Married /Union   71 (30.9) 46 (33.1) 
Missing 4 (1.7) 2 (1.4) 
Gestational age     
22-27 weeks 1 (0.4) 0  
 
 
p=0.324 
28-31 weeks 2 (0.9) 0 
32-36 weeks 17 (7.4) 6 (4.3) 
37-41 weeks 208 (90.4) 129 (92.8) 
≥42 weeks 2 (0.9) 3 (2.2) 
Missing 0  1 (0.7) 
Birth or death weight     
≥2,500 210 (91.3) 134 (96.4) 
p= 0.064 
1,500-2,500 19 (8.3) 4 (2.9) 
<1,500 1 (0.4) 1 (0.7) 
Missing    
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Chapter 5. Linkage procedures and validation – description of the maternal death 
linkage process   
 The linkage between maternal deaths and women notified with dengue could have 
been done by linking information belonging to the same person woman-woman (woman 
notified with dengue and woman who died). It would have increased the number of 
common identifiers in the datasets improving the quality of the linkage. However, as 
discussed before, to estimate the association between dengue during pregnancy and 
maternal deaths, the comparison group is live births. In this case, if the linkage were 
performed directly (cases of dengue and maternal deaths), there would be a variation in 
the quality of the linkage to assess the exposure (dengue status) between maternal deaths 
and live births. In this case, the linkage would perform better among the cases (maternal 
deaths) compared with the comparison group (live births), introducing a differential error. 
In these circumstances, the linkage of maternal deaths would have a better sensitivity than 
the linkage among live births; therefore, the measure of association would be 
overestimated.  
 To avoid this issue, I proposed an indirect linkage. In brief, I used the composite 
file (dengue notifications and live births/stillbirths) of the linkage described above to link 
with maternal death records. This method will be explained in detail in the following 
paper. Another advantage of this is the overlapping between the datasets (maternal deaths 
and fetal outcomes –livebirth/stillbirth); consequently, there was an expected number of 
known matched records.  
 
 
 
104 
 
Cover sheet  
 
105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
Paper 3 title: Validating linkage of multiple population-based administrative 
databases in Brazil  
 
Authors: Enny S. Paixao, Oona Campbell, Laura C. Rodrigues, Maria Gloria 
Teixeira, Maria da Conceicao N Costa, Elizabeth B. Brickley, Katie Harron 
 
Author contribution:  
ESP carried out the analysis and wrote the first draft of the article. LCR, KH conceived 
the study. OC, MCNC and MGT contributed to the study design and interpretation. EBB 
contributed with the revision of the first draft. All authors revised the manuscript and 
approved the final version. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
107 
 
Validating linkage of multiple population-based administrative 
databases in Brazil  
 
 
 
 
 
Enny S Paixão*, MSc1 
Oona Campbell, PhD1  email address: oona.campbell@lshtm.ac.uk  
Laura C. Rodrigues, PhD1  email address: laura.rodrigues@lshtm.ac.uk 
Maria Glória Teixeira, PhD2 email address: magloria@ufba.br 
Maria da Conceição N. Costa, PhD2 email address: mcncosta@ufba.br 
Elizabeth B. Brickley, PhD1  email address: elizabeth.brickley@lshtm.ac.uk 
Katie Harron, PhD1   email address: katie.harron@lshtm.ac.uk 
 
 
 
 
 
 
* Corresponding author email: enny.cruz@lshtm.ac.uk 
1 London School of Hygiene and Tropical Medicine. Keppel St, Bloomsbury, London WC1E 7HT, United Kingdom 
2 Instituto de Saúde Coletiva. Rua Basílio da Gama, s/n.Canela. CEP 40110040. Salvador, Bahia, Brazil. 
 
108 
 
Abstract  
Background: Linking routinely-collected data provides an opportunity to measure 
the effects of exposures that occur before birth on maternal, fetal and infant outcomes. 
High quality linkage is a prerequisite for producing reliable results, and there are specific 
challenges in mother-baby linkage. Using population-based administrative databases 
from Brazil, this study aims to estimate the accuracy of linkage between maternal deaths 
and birth outcomes linked with dengue notifications, and to identify potential sources of 
bias for assessing the risk of maternal death due to dengue in pregnancy.  
Methods: Women with dengue during pregnancy were identified from a 
previously linked dataset of dengue notifications in women who had live births or 
stillbirths during 2007-2012. We linked this dataset with maternal death records using 
probabilistic linkage with maternal name, age and municipality. We estimated the 
accuracy of the linkage and examined the characteristics of false-matches and missed-
matches to identify any sources of bias. 
Results: Of 10,259 maternal deaths recorded in 2007-2012, 6717 were linked: 
5444 to a live birth record, 1306 to a stillbirth record, and 33 to both a live and stillbirth 
record. After identifying 2620 missed-matches and 124 false-matches, estimated 
sensitivity was 72%, specificity was 88%, and positive predictive value was 98%. 
Linkage errors were associated with maternal education and skin colour; women who had 
more than 7 years of education or self-declared as Caucasian were more likely to link. 
Dengue status was not associated with error.  
Conclusion: Despite a lack of unique identifiers for linking mothers and birth 
outcomes, we demonstrate a high standard of linkage, with sensitivity and specificity 
values comparable with previous literature. Although there were no differences in the 
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characteristics of dengue cases missed or included in our linked dataset, linkage error 
occurred disproportionally according to some social-demographic characteristics, which 
should be taken into account in future analyses.  
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Background 
Research involving record linkage has increased in recent years with the rising 
availability of administrative population-based health databases and the relatively low 
costs of bringing together information from different sources. Linkage has been 
particularly important for research on maternal, fetal and infant health. Information on 
maternal health and women’s social contexts prior to and during pregnancy can be linked 
with fetal and childhood outcomes beyond the limits of traditional cohort studies. Due to 
the large scale and availability of population-based datasets and because these data are 
collected routinely (i.e., do not require a large cohort with many years of follow up to be 
established), rare or long-term outcomes can also be investigated. In the past decade, 
many developed countries have used linkage to investigate the health of mothers and their 
babies 1–5. However, for developing countries, record linkage methods have only been 
developed more recently 6.     
The quality of the linkage is important for producing reliable results, and there are 
specific challenges in mother-baby linkage, mainly due to the limited availability of 
common identifiers for linkage 1. The impact of linkage error depends on the question of 
interest 7. For example, linkages with low sensitivity cannot be used to measure the 
incidence of a given disease, such as cancer, in a population, otherwise the measure 
calculated will be underestimated 8. However if the study presents a low sensitivity 
randomly distributed between groups, the measure of association will not be biased, so it 
can be useful under this circumstance,  as shown in the study of dengue during pregnancy 
and stillbirth8. In other studies, it may be more important to prioritise specificity over 
sensitivity. For example, in case-control studies, we may be more concerned with 
precisely establishing exposure status through linkage, rather than capturing all links 6. In 
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this case, it is also important to avoid selection bias (if missed-matches are non-random, 
i.e. are more likely to occur in specific subgroups of records).  
This linkage study is part of a series of studies measuring the association between 
dengue and pregnancy outcomes 6,9. In this particular article, we aimed to validate our 
linkage strategy discussed in Paixao et al 20176, to facilitate a cohort study on the effects 
of dengue on maternal and birth outcomes, in which linkage was required to establish 
exposure status. Evaluating a linkage strategy with a dataset for which we have, a priori, 
information on the expected number of matches (a maternal mortality dataset) gives us 
information about the likely quality of the same linkage strategy when applied to linkage 
between datasets where the expected number of matches is not known (linkage between 
live births, stillbirths and dengue notifications). The purpose of the analysis presented 
here (linkage of maternal death records with live births and stillbirths in the context of 
maternal dengue infections) was to investigate whether any linkage errors were 
disproportionately distributed amongst the group with the outcome (maternal death) and 
the comparison group (mothers who did not die). This was important to establish any 
potential bias in the linked dataset, which might influence subsequent analyses. We aimed 
to estimate the accuracy of the linkage and identify potential sources of bias, where any 
subgroups of records were more or less likely to link.  
Methods 
Datasets 
We linked three routinely collected Brazilian datasets: a) notifications of 
infectious disease (SINAN) for dengue; b) Live Births Information System (SINASC) for 
live births; and c) Mortality Information System (SIM) for stillbirths and maternal deaths. 
The datasets were linked in two stages (Figure 1). First, we probabilistically linked 
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dengue notifications in women (SINAN) with records of women who had live births 
(SINASC) or stillbirths (SIM), to identify those women who had dengue during 
pregnancy during 2007-2012. This first linkage (between dengue notifications and live 
births/stillbirths) has been described in detail elsewhere 6. Second, we linked this 
composite file (women with a live birth/stillbirth linked with a dengue notification) with 
maternal death records for 2007-2012. In this paper, we focus on the results of this second 
stage of the linkage. 
In both linkage processes we used the common variables in all three datasets: 
maternal name, maternal age, and place of residence. For linkage with death records, we 
also used information on time between the maternal death and birth outcome in the 
algorithm, because maternal deaths are likely to occur in the same period (often on the 
same day) as the birth outcome. Therefore, the timing of these dates contributed 
information on the likelihood of two records being a match.   
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  Data Source 1: Brazilian Notifiable Diseases Information System -SINAN 
 
The Brazilian Notifiable Diseases Information System (Sistema de Informação de 
Agravos de Notificação; SINAN) contains records on notifiable diseases, characteristics 
of the individual with the disease (name, place of residence, age, sex, and years of 
education), symptoms of the disease, laboratory tests, and disease severity.  
After excluding men, and non-dengue records, we retained 1,725,943 cases of 
dengue from 2007-2012. This is likely an underestimate of the burden of disease, as most 
dengue cases are not reported to the National Surveillance system in Brazil. For every 
notified case, there are an estimated 12 dengue cases in the community 10.   
Data Source 2: Brazilian Live Birth Information System -SINASC 
 
The Brazilian Live Birth Information System (Sistema de Informação sobre 
Nascimentos; SINASC) contains records of all live births in Brazil; these data come from 
birth registration, a legal document completed by the health worker who attended the 
birth. It includes information on the mother (name, place of residence, age, marital status, 
education); the pregnancy (length of gestation, type of delivery); and the neonate (birth 
weight, the presence of congenital anomalies). According to an evaluation of the birth 
registration system in Brazil, 97% of Brazilian live births are registered.  
 
Data Source 3: Brazilian Mortality Information System -SIM 
 
The Brazilian Mortality Information System (Sistema de Informação sobre 
Mortalidade; SIM) contains records of all deaths in Brazil, including stillbirths (stillbirth 
in Brazil is defined as the death  of a product of conception before the expulsion or 
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complete extraction from the body of the pregnant woman, occurring from 22 weeks or 
weighing more than 500g). These data come from the Death Certificate, a required legal 
document. We retained all maternal deaths, defined as those coded under obstetric causes 
of death by ICD-10, the "O" group), and all stillbirths. 
 
It is possible that stillbirths are under-reported in the national system 11. However, 
it is difficult to estimate the rate of under-ascertainment. After exclusion of records 
without the name of the mothers, we retained 187,487 stillbirth records and 10,259 
maternal deaths (with an obstetric code in ICD-10 recorded as the cause of death) 
extracted from SIM (2007-2012).  
Completeness of linkage variables 
Table 1 contains information on the number of missing values in the variables 
used in the linkage process in the three datasets (SIM, SINAN and SINASC).   
 
Table 1. Missing data for the Brazilian Notifiable Diseases Information System, the Brazilian Live 
Birth Information System, and the Brazilian Mortality Information System, 2007-2012. 
Databases Records 
Percentage missing 
Maternal 
name 
Maternal 
age 
Municipality 
Notifiable Diseases Information System (Sistema 
de Informação de Agravos de Notificação; 
SINAN) 
1,725,943 0.4% 0.07% 0% 
Live Birth Information System (Sistema de 
Informação sobre Nascimentos; SINASC) 
17,387,267 0.03% <0.01% 0% 
Mortality Information System (Sistema de 
Informação sobre Mortalidade; SIM). Stillbirths 
187,487 2% 15% 0% 
Mortality Information System (Sistema de 
Informação sobre Mortalidade; SIM). Maternal 
Deaths 
10,259 0% 18.5% 0% 
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Ethics approval and consent to participate 
Ethical approval was obtained from the Research Ethics Committee, Public 
Health Institute, Federal University of Bahia, Salvador, Brazil (CAAE: 
26797814.7.0000.5030 CEP-ISC) and from London School of Hygiene and Tropical 
Medicine (Ethics Ref: 10269).  
Linkage strategy  
We derived our pre-processing and blocking schemes, gold-standard data and 
match weights based on previous linkage of Brazilian birth data, as described by Paixao 
et al (2017)6. Firstly we cleaned and prepared the data: we excluded records without 
names, those with generic names such as “ignorado, hospital name”, and deleted 
punctuation and consecutive spaces, and unknown prefixes. We transformed known 
abbreviations for names (e.g. Ap  Aparecida) into full names, and all names into upper 
case, dropping middle initials. We then blocked the records by municipality and used the 
Jaro-Winkler string comparator to calculate the similarity between names recorded in 
each dataset 12.  
To estimate parameters for linkage weights and to validate the quality of the 
linkage, we created a gold-standard dataset. Firstly, we linked the dataset using 
deterministic linkage with exact agreement on full name and age. Subsequent steps 
relaxed the rules by allowing matches with differences in the age and for differences in 
the ways names were recorded. Each step was followed by manual review to exclude 
false-matches 6.  
Match weight calculations were based on the Fellegi-Sunter method 13. For each 
record pair we calculated a probabilistic match weight based on two conditional 
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probabilities: m-probability, P (agreement|match) and u-probability, P (agreement|non-
match). We estimated m-probabilities for each identifier from the true matches in the 
gold-standard dataset. We calculated u-probabilities based on a list of non-matches, 
created from all pairwise comparisons of records within SINAN, excluding those 
belonging to the same individual.  
Frequency-based weights were calculated for each category of Jaro-Winkler score 
comparator (for name of the woman) and year of age, so that rarer values were given 
higher weights. Separate weights were also calculated for the five most frequently 
occurring names in the data (Maria, Ana, Santos, Souza and Oliveira).  
Since we were linking different subjects (the woman and her live or stillbirth), 
and because the exposure (dengue during pregnancy) could have happened up to nine 
months before the outcome (birth/ maternal death), there were timing issues to consider. 
Two records could differ in time by nine months and could bridge over a calendar year; 
some mothers would have a birthday between the data of dengue notification and the date 
of the live birth/death. To allow for this, we estimated different weights according to the 
similarity of age across datasets: equal ages, age differing by one year, age differing by 
two years, and ages differing by more than two years. In the maternal mortality linkage, 
we included the time between the birth outcome and death of the mother as linkage 
variable (occurred at the same day as the birth outcome; between 2-7 days; between 8-15 
days; between 16-30 days; after 30 days).  
Match weights were calculated by summing the log of the ratio of m-probabilities 
and u-probabilities across different identifiers. The algorithm was implemented in Stata 
14.1 and R 3.4.1.  
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Records pairs were ordered by match weight and manually inspected to identify a 
conservative threshold values aiming to exclude as many as false-matches as possible 
(prioritising a high positive predictive value). Any records above the cut-off threshold 
were classified as links.  
Statistical analysis and evaluation of linkage quality  
For the first linkage stage (of women with dengue notification with those with live 
births/stillbirths), the expected number of matches was unknown a priori, as we did not 
know how many pregnant women were expected to link with a dengue notification 
registered in SINAN. These findings are described by Paixao 2017 6.  
For the second linkage stage (of maternal mortality), we expected all maternal 
deaths would link with a live birth or a stillbirth after excluding women with maternal 
deaths coded under pregnancy with abortive outcome (ICD-10 codes O00-O08; 10% of 
maternal mortality notifications). We therefore expected around 90% of maternal 
morbidity records to have a pregnancy outcome (stillbirth or live birth) and therefore be 
linked with one of our datasets. We used this value to identify the number of missed 
matches (records from the same mother-baby pair that failed to link) and to estimate the 
sensitivity of the linkage.  
To estimate the proportion of false matches (records from different mother-baby 
pairs that are linked), we looked at women who were coded as having died in a pregnancy 
with an abortive outcome (i.e. those who should not have linked with a live birth/stillbirth 
record). Those who did link were assumed to be false-matches, as were those who linked 
to a live birth and a stillbirth simultaneously, unless they were multiple births.  
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We then examined which characteristics were associated with missed matches in 
the maternal mortality dataset (since we expected more missed matches than false 
matches). We compared the characteristics of maternal deaths classified as having dengue 
through linkage, with maternal deaths where dengue was coded as an underlying cause 
of death (using ICD-10 codes) but that were missed from our linkage. We examined 
maternal age in years (continuous variable), maternal education (illiterate to 3 years or 
education,  4-7 years of education, more than 7 years or education), maternal marital 
status (married, divorced/widow or single), self-declared skin colour (Caucasian, 
mixed/black, and other) and classification of deaths occurring during pregnancy or 
puerperium. Categorical variables were compared between groups with Chi2 test or 
Fisher’s exact test, and means were compared with a t-test. A two-sided P value of less 
than 0.05 was considered to indicate statistical significance. Stata version 14.1 was used 
for the statistical analyses. 
Results  
Maternal Mortality linkage  
Of the 10,259 maternal deaths in SIM from 2007-2012, 6717 were linked: 5,444 
(53%) were linked to a live birth record, and 1,306 (13%) were linked to a stillbirth record. 
Of these linked records, 33 linked to both a live and stillbirth simultaneously: 20 were 
multiple pregnancies (with a live birth and stillbirth outcome); 3 were duplicate records 
(stillbirths misreported as live births and notified in both datasets); and 10 were classified 
as false matches. After excluding these, 3542 maternal deaths remained unlinked (Figure 
2). 
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 Figure 2: Linkage description 
 
 
 
Of the 10,259 maternal deaths, 1,046 (10%) were coded in SIM as being 
pregnancies with an abortive outcome, which we did not expect to link to a live or 
stillbirth. Of these pregnancies with an abortive outcome, 124 (12%) linked (i.e. were 
false matches); 55 linked with a live birth and 71 linked with a stillbirth (two linked with 
both). This gave an estimated specificity of 922/1046=88% (Table 2). However, since 
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misclassification of abortion and stillbirth is very common (with either a stillbirth being 
coded as an abortion or an abortion as a stillbirth), we also estimated the specificity for 
linkage with live births only, which gave a specificity of 991/1046=95%.  
Table 2: Linkage accuracy 
 
 
After excluding the 1,046 maternal deaths with abortive outcomes from the 
10,259 coded pregnancies, we expected that the remaining 9,213 maternal death records 
would all have linked with a live birth record or a or stillbirth record. Instead, we observed 
only 6717 linked records, of which 124 were the aforementioned false matches and 6,593 
were true links (Table 2). This is an estimated sensitivity of 6,593/9213=72% and a 
positive predictive value (PPV) of 6593/6717=98%.  
Maternal mortality and live births/stillbirths linkage errors  
Missed matches were not associated with age or marital status (Table 3). Records 
were more likely to link if women had more than 7 years of education or self-declared as 
Caucasian. Records were also more likely to link if maternal death occurred in the 
puerperium than if records classified the death as occurring during pregnancy.  
 
 
 
 
 Match Non-match  
Link 6593 124 6717 
Non-link 2620 922 3542 
 9213 1046 10259 
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Table 3. Associations between linkage accuracy and maternal characteristics   
 
True matches  
N=6593 
n (%) 
Missed-matches  
N=2620 
n (%) 
 
OR(95%CI) p-value 
Age of the mother in 
years 
  
 
 
Mean age  28.4 28.7 - 
0.127 
    
Maternal literacy    
 
 
More than 8 years 2,236 (33.9) 750 (28.6) 1 
<0.001 
4-7 years 1,773 (26.9) 699 (26.7) 0.85 (0.75-0.96) 
Less than 3 years 1,009 (15.3) 510 (19.5) 0.66 (0.58-0.76) 
Missing  1,575 (23.9) 661 (25.2)  
Marital status    
 
 
Single  3,615 (54.8) 1,427 (54.5) 1 
0.611 
Married  2,264 (34.3) 914 (34.9) 0.98(0.89-1.1) 
Divorced/widow 148 (2.3) 68 (2.6) 0.85 (0.64-1.1) 
Missing 566 (8.6) 211 (8.0)  
Self-declared skin colour    
 
 
White 2,322 (35.2) 846 (32.3) 1 
0.005 
Mixed and black 3,787 (57.4) 1,583 (60.4) 0.87 (0.79-0.96) 
Others  91 (1.4) 51 (1.9) 0.65 (0.45-0.92) 
Missing  393 (6.0) 140 (5.3)  
Pregnancy      
Pregnant  1,173 (17.8) 1,331 (50.8) 1 
0.001 Puerperium  4,870 (73.9) 993 (37.9) 5.5 (5.0-6.1) 
Missing  550 (8.3) 296 (11.3)  
 
Maternal Mortality linkage and dengue  
We identified 23 maternal deaths that were coded in SIM with ICD-10 codes for 
dengue as the underlying cause of death, but that had not linked to the dengue notification 
cases in our linkage. The reasons were: a) the maternal death was in a pregnancy with an 
abortive outcome (the record should have been excluded from the previous linkage, n=3 
cases); b) the maternal death record did not link with live birth or stillbirth (missed match, 
n=8 cases); c) the maternal death linked with a live birth or stillbirth, but not to the dengue 
notifications (misclassification of dengue status, n=12 cases). We investigated these latter 
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12 cases further, finding that in  5/12 cases, the symptoms of dengue began in the 
puerperium, more than 42 days after the fetus was born, and therefore were classified as 
no dengue during pregnancy in the previous linkage; 1/12 cases were classified as an 
uncertain link; the remaining 6/12 were false-matches in the original linkage.    
Excluding the three abortive outcomes, there were no differences in socio-
demographic characteristics between the 20 records that our linkage failed to identify, 
and the 14 cases of dengue identified in our linkage of maternal mortality and dengue 
datasets.  
 
Discussion  
We implemented the linkage methods described by Paixao et al (2017) 6 in a 
dataset with a known number of expected matches, and consequently were able to 
quantify measures of linkage accuracy and validate our previous linkage strategy. We 
therefore demonstrate that the quality of a particular linkage strategy can be validated 
using a dataset where the expected number of matches is known. Due to the lack of 
common variables for linkage, it was not possible to increase the sensitivity without 
increasing the number of false matches. However, our linkage achieved a PPV of 98%, 
indicating that the majority of links that were made were correct. In our evaluation of 
linkage error, we observed that mothers with fewer years of education and mixed ethnic 
background were more likely to be missed from the linkage. However, there were no 
differences in the socio-demographic characteristics between the cases of dengue 
identified in our linked dataset, and those that were missed, to dengue status groups.  
Linkage to bring together information from two different sources about the same 
individual can achieve high rates of sensitivity, even when using records containing 
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truncated or ambiguous matching variables 14–16. However, bringing together information 
from two different people (in this case, mother and baby) has been considered a more 
difficult task, due to a lack of common variables. Sensitivity in these cases tends to be 
lower, e.g. 38% missed links in Georgia 17 and 20% in New Jersey 18; rates that are 
comparable with our results (28% missed records). Specificity in our study was estimated 
at between 88% (pregnancies with an abortive outcome that linked with either live or 
stillbirths) and 95% (pregnancies with an abortive outcome that linked with live births 
only), but it was difficult to distinguish between false matches and misclassification of 
stillbirths/abortive outcomes.         
A very important aspect of linkage is how any linkage error might impact on 
inferences from the linked dataset. The analyst should know and report any evaluation of 
linkage accuracy and be aware of groups disproportionately affected by linkage error 19,20. 
In this study, we found differences between the matches and the residual (non-linked) 
records: the matches were more likely to have more than 7 years of education and self-
declare as Caucasian compared with the non-links. Adams et al in USA found that 
incomplete records were related to social disadvantage and consequently these records 
were less likely to match 17.  
 
Beyond socioeconomic status, there are other possible explanations for the 
distinctive characteristics observed in the non-linked group. First, completion of the 
forms by health care professionals and the process of digitalization in private and public 
health facilities may result in differential quality of records. Second, in Brazil, induced 
unsafe abortion has been associated with low education and income 21,22, and because it 
is illegal, it may be that some missed maternal death matches had an abortive outcome 
resulting from an illegal and unsafe abortion, which were coded under a different cause 
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of death in the legal document. Therefore the missed-matches may not all be linkage 
errors but coding errors, which would explain the differences observed between these two 
groups. The fact that most of the missed-matches occurred during pregnancy rather than 
postpartum supports this hypothesis.  
To further evaluate the linkage accuracy on the dengue status of the pregnant 
women (exposure variable), we compared the dengue cases that the algorithm was 
capable of capturing, with those that it could not (i.e., those identified in post-hoc analyses 
as individuals coded with dengue as cause of death), and found no difference in socio-
demographic characteristics between the two groups. It is therefore unlikely that the 
linkage process introduced bias in our previous linkage of live births/stillbirths and 
dengue, since missed matches occurred randomly in relation to the exposure variable. 
However, this analysis had limited power because of the sample size (34 cases of dengue). 
Therefore, results showing no difference between the two groups should be interpreted 
with caution.  
This study has a number of limitations. We did not have information about the 
gestational age at which the maternal death occurred, and so we cannot conclude if the 
missed-matches occurred due to linkage errors, or if they should not have been linked 
(i.e., were abortive outcomes). It is possible that we have under estimated the number of 
false-matches, but we expected all the maternal deaths to link, it is unlikely that records 
have linked to the wrong record, because that record would also have been linked. Due 
to the restricted number of variables, we could not improve the sensitivity of the 
algorithm, and so our linked dataset should not be used to estimate rates of live births or 
maternal mortality rates for women exposed to dengue during pregnancy. Our analysis of 
the association between study characteristics and linkage error may have been limited due 
to low power. Finally, we assumed that linkage quality metrics in our maternal mortality 
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linkage would be representative of those in our initial linkage between birth outcomes 
and dengue notifications, since the data are derived from similar sources and contain the 
same matching variables.   
It is important to understand the quality of the linkage and the potential bias that 
can be introduced in results of analyses of linked data. In this study, sensitivity and 
specificity of our linkage strategy were comparable with previous literature. Although 
there were no differences in the characteristics of dengue cases missed or included in our 
linked dataset, linkage error occurred disproportionately according to some social-
demographic characteristics, which should be taken into account in future analyses. These 
results reinforce the need to evaluate linkage quality and to take linkage error into account 
within analyses of the following studies when necessary.  
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Results Section  
Overview 
This section presents the estimated association between maternal dengue infection 
and pregnancy outcomes. I analysed the data obtained after the linkage process, and each 
chapter is one paper and discuss one specific outcome. The chapter 6 (paper 4) describe 
the association between symptomatic dengue and stillbirth. Chapter 7 (paper 5) estimate 
the association between maternal dengue and live birth outcome (premature birth, low 
birth weight and small for gestational age), and finally chapter 8 (paper 6) presents the 
results for maternal deaths. As a paper style thesis there is some repetition of information.  
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Chapter 6. Description of the association between symptomatic dengue during 
pregnancy and stillbirth 
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Abstract 
Background: Dengue is the most common viral mosquito-borne disease, and 
women of reproductive age who live in or travel to endemic areas are at risk. Little is 
known about the effects of dengue during pregnancy on birth outcomes.    
Methods: We conducted a population-based cohort study using routinely-
collected Brazilian data from 2006-2012. We used birth registrations to identify 
pregnancies and linked to identify mothers of live births with dengue notified during 
pregnancy. Using multinomial logistic regression and Firth method, we estimated risk 
and odds ratios for preterm birth, low birth weight and small for gestational age associated 
with dengue. We also investigated the effect of time between the onset of the disease and 
the outcome.  
Findings: We included 16,738,000 live births. Dengue haemorrhagic fever 
doubled the risk of preterm birth OR=2.4;95%CI 1.3-4.4 and low birth weight 
OR=2.1;95%CI 1.1-4.0 and did not have an effect on small for gestational age 
OR=2.1;95% CI 0.4-12.2). The magnitude of the effects was higher in the acute disease 
period.   
Conclusion: This study showed an increased risk of adverse fetal outcomes in 
women with severe dengue during pregnancy. It appears that one contributing factor may 
be medical intervention to mitigate maternal risk with severe acute dengue.  
Key words: Dengue, pregnancy, birth outcomes 
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Summary  
In this paper, we analyzed the effects of symptomatic dengue during pregnancy 
on birth outcomes (preterm birth, low birth weight, small for gestational age) by dengue 
severity and time between the onset of disease and birth outcome. Our results have shown 
that dengue haemorrhagic fever in pregnant women doubled the risk of preterm birth and 
of low birth weight; however we did not find an affect in small for gestational age for 
either severe or mild disease. The main dengue effect on birth outcomes occurred during 
acute disease, 10 days between dengue onset and birth outcome and possibly one 
contributing factor to these adverse birth outcomes may be medical interventions 
triggered to mitigate mothers risk associated with dengue haemorrhagic fever. Therefore, 
in areas where dengue is circulating, the health of birth outcome should be a concern and 
this disease highlighted as public health priority.   
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Introduction  
Dengue is the most common viral vector-borne disease worldwide, with an 
estimated 390 million people infected each year, 96 million of whom will develop clinical 
symptoms. It is endemic in over 100 countries (mostly in South and Central American 
and Southeast Asia), and is spreading to new areas; according to the World Health 
Organization (WHO), approximately half of the world’s population is at risk 1. Since 
women of reproductive age who live in or travel to endemic areas are at risk of dengue, 
and since the effect of this disease during pregnancy is still unclear, it needs to be 
investigated. The majority of studies published to date are cases series2; the seven studies 
published before 2016 with comparison groups show conflicting results 3 4 5 6 7 8 9 and a 
meta-analysis published in 2016 found dengue during pregnancy was only associated 
with low birth weight and preterm birth in symptomatic women2. In 2017, a large 
Brazilian study found that notification of mild dengue during pregnancy was not 
associated with higher rates of preterm birth or lower birth weight in neonates compared 
to rates in a random sample of all neonates. However, the study found an increase in the 
risk of preterm birth among women with confirmed dengue compared with reported 
maternal dengue cases with a dengue negative test10.  
Maternal dengue, especially severe dengue, has been associated with fetal deaths11 
but the effects on those who survive, especially when the mothers progress to severe 
disease, needs to be better investigated. We analysed a large, population-based, 
retrospective cohort to investigate the association between symptomatic dengue notified 
during pregnancy and adverse fetal outcomes, and to examine the effect of maternal 
dengue severity on outcomes. 
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Methods 
We conducted a population-based retrospective cohort study by linking routine 
records of live births with records of women notified and confirmed with dengue disease, 
in Brazil from January 1, 2006 until December 31, 2012.  
Data sources 
We extracted routinely collected data from two Brazilian databases.  
1) The Live Births Information System (Sistema de Informação sobre 
Nascimentos; SINASC), which records live births in Brazil; these data are derived from 
the birth registration, a legal document completed by the health worker who attended the 
birth. It includes information on the mother (name, place of residence, age, marital status, 
education); the pregnancy (length of gestation, mode of delivery); and the neonate (birth 
weight, presence of congenital anomalies) 12. Data completeness is very high, with 97% 
of Brazilian births registered,13 and most variables were >90% complete14.  
2) Notifiable Diseases Information System (Sistema de Informação de Agravos 
de Notificação; SINAN), which records notifiable diseases. Dengue notifications 
information on the individual (name, place of residence, age, sex, and years of education), 
symptoms of the disease, laboratory tests, and disease severity, assessed clinically and 
laboratory according with the Brazilian dengue manual 15. These data are reasonably 
complete on the variables used for linkage: <0.05% records were excluded because of a 
missing name. Around 5% of dengue cases did not have a final classification of severity. 
Laboratory confirmation was not required for notification or confirmation of dengue. 
During the study period (2006-2016), dengue was the main (and sometimes the only) 
vector-borne disease circulating in Brazil, as yellow fever and malaria occurred in 
restricted areas, and Zika and Chikungunya did not begin to circulate until 2014. 
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Procedures 
SINASC defines a live birth as the product of conception that, independent of the 
duration of pregnancy, breathes or shows any other signs of life (such as a heartbeat, 
umbilical cord pulsation, or definite movement of voluntary muscles), after the separation 
from the mother's body 12. Live birth records with a missing or implausible name of the 
mother (e.g. the name of a hospital as the name of the mother, twin or other multiple 
pregnancies, or congenital anomalies, or coming from municipalities without dengue 
notifications, and those with uncertain link status) were excluded (Figure 1).  
 
 
152 
 
Outcomes  
We assessed three birth outcomes: preterm birth (<37 weeks); low birth weight 
(<2500g) and small for gestational age), calculated according to the Intergrowth scale 16 
using the weight and gestational age in weeks at birth. This scale is sex specific, and those 
babies with a birth weight less than the 10th centile were considered small for gestational 
age. The data to calculate this outcome were available only for 2011 and 2012 (prior to 
this, gestational age was categorized).  
Exposure  
The exposure was being a confirmed case of dengue notified to SINAN during a 
pregnancy that resulted in a live birth. In Brazil, confirmation of dengue is based either 
on clinical and epidemiological criteria, namely presence of clinical symptoms of dengue 
in the same area and time as other confirmed cases of dengue, or on clinical and laboratory 
criteria, namely the presence of clinical symptoms and a positive test for one of: a) IgM 
detection by ELISA, b) viral RNA detection via PCR, c) NS1 viral antigen detection, or 
d) positive viral culture. Laboratory confirmed cases used in the analyses were referred 
to as “dengue during pregnancy, laboratory confirmed”. The notification does not 
necessarily state the woman notified was pregnant – there is a field for this variable, but 
it is largely missing. Rather, we considered a woman to be a case of dengue in pregnancy, 
and her newborn to be  “exposed”, if the woman was notified to SINAN and confirmed 
as a dengue case and she linked to a live birth in the nine months after notification. We 
used the clinical classification valid in Brazil in the period in which data were collected, 
which classified dengue into three clinical categories: a) “dengue fever”, b) “complicated 
dengue”, and c) “dengue haemorrhagic fever/ dengue shock syndrome”. a) Dengue fever 
is a self-limiting disease, characterized as fever, with a severe headache, pain behind the 
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eyes, muscle and joint pain, and rash; b) Dengue haemorrhagic fever follows the WHO 
criteria and is characterized by fever, haemorrhagic evidence, thrombocytopenia and 
evidence of plasma leakage; c) Complicated dengue is a probable case of dengue 
characterized by one of the following: severe changes in the nervous system, 
cardiorespiratory dysfunction; insufficient hepatic function; gastrointestinal bleeding, 
cavity spills, or thrombocytopenia equal or less than 50,000/mm3, or leucometry less than 
1000/mm.17. Complicated dengue is a Brazilian definition for severe cases of dengue that 
do not meet WHO criteria for dengue haemorrhagic fever and cannot be classified as mild 
self-limited disease due to their severity;  
Linkage process  
The data used in the linkage process were identified because we probabilistically 
linked records of women with confirmed dengue (SINAN) with records of live births 
(SINASC) up to nine months after the SINAN notification, to identify those mothers who 
had dengue during pregnancy. For this, we used name, age or date of birth, and the place 
of residence of the mother at the time of delivery and of notification. We excluded records 
with missing or implausible names (Figure 1). Match weight calculations used the Fellegi-
Sunter method.18 
Linkage followed the same procedure as previously described for linking stillbirth 
records and the dengue database in Brazil, in which we demonstrated a sensitivity of 62% 
and a positive predictive value of 95%.19 To estimate parameters for linkage weights and 
to validate the quality of the linkage, we created a gold-standard dataset. For the dengue-
live birth linkage, we used all live birth records in Ceará and Espirito Santo States for 
2010. Record pairs were manually reviewed to establish true matches (records belonging 
to the same mother) and to derive match weights. Records pairs were then ordered by 
match weight and manually inspected to identify any errors in linkage (false matches or 
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missed matches). Live birth records linked to confirmed dengue notifications with high 
certainty were classified as dengue in pregnancy cases, and birth records we were 
confident had no link were classified as non-dengue cases. Uncertain links (where we 
could not establish whether a woman had dengue) were excluded to avoid 
misclassification.  
Statistical analysis 
The data used in the analysis were de-identified. We estimated the crude and 
adjusted risk ratios from multinomial logistic regression, controlling for maternal age 
(categorized as <=20; between 20-35 and >=35 years old), education (less than 3 years; 
between 4-7 years and more than 8 years) and marital status (single/ widow /divorced or 
married/stable union). For a sensitivity analysis of the validity of clinical/epidemiologic 
diagnosis, we repeated the analyses using laboratory confirmed dengue only. We 
investigated the effect of time between  disease onset and live birth outcomes of preterm 
birth, low birth weight, and small for gestational age. In general, dengue is an acute 
disease with rapid recovery. The time between disease onset and the outcome was 
calculated using the date of the disease onset (information available in SINAN) and the 
date when the outcome occurred (date of live birth); we categorized this difference as 
being less than or equal to ten days or greater than 10 days.  For the analyses by dengue 
severity (mild dengue, dengue with complications and dengue haemorrhagic fever), we 
calculated the odds ratio because we used the Firth method (to reduce the small sample 
bias in maximum likelihood estimation) as we were analysing rare events, and controlled 
for maternal age, education and marital status 20.       
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Ethics Statements  
Ethical approval was obtained from The Federal University of Bahia, Salvador, 
Brazil (CAAE: 26797814.7.0000.5030) and from The London School of Hygiene and 
Tropical Medicine (Ethics Ref:10269).  
Results  
The SINASC recorded 20,333,482 live births from 2006-2012. After exclusions, 
16,738,000 live births were included in the study, and 17,673 (0.1%) of their mothers 
were linked with a dengue notification record (Figure 1).  
The cohort characteristics by dengue status are described in Table 1. Compared to 
pregnant women without dengue, pregnant women with dengue were more likely to have 
more years of formal education and to have delivered by caesarean-section.  
Table 1. Maternal characteristics, delivery details, and birth outcomes in relation to dengue status, 
Brazil, 2006-2012 
Characteristics  
Notified with 
confirmed dengue 
in pregnancy 
Without dengue 
notification 
p value  
n (%) n (%)  
 
Age of the mother  
 
< 20 4,499 (25.5) 4,384,159 (26.2) <0.001 
20-35 11,981 (67.8) 11,042,342 (66.0) 
>35 1,193 (6.7) 1,293,171 (7.8) 
Missing - 655 (0.0)  
 
Maternal education  
 
Less than 3 years    1,065 (6.1) 1,358,815 (8.3) <0.001 
4-7 years 4,661 (27.0) 4,592,979 (28.1) 
More than 8 years 11,578 (66.9) 10,399,703 (63.6) 
Missing  369 (2.1) 368,830 (2.2) 
    
Marital status     
Single/Widow/Divorced 11,518 (66.1) 9,660,306 (58.7) <0.001 
Married /Union   5,899 (33.9) 6,797,658 (41.3) 
Missing  256 (1.4) 262,363 (1.6) 
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Characteristics  
Notified with 
confirmed dengue 
in pregnancy 
Without dengue 
notification 
p value  
n (%) n (%)  
Numbers of pre-natal visits    
Inadequate (less than 7 times) 6,991 (39.9) 6,817,679 (41.2) <0.001 
 Adequate (7 or more times) 10,515 (60.1) 9,712,338 (58.8) 
Missing 167 (0.9) 190,310 (1.1) 
    
Delivery     
Vaginal  8,332 (47.2) 8,383,714 (50.2) <0.001 
C-section  9,320 (52.8) 8,307,072 (49.8)  
Missing  21 (0.1) 29,541 (0.2)  
    
Gestational age in the delivery    
Less than 22 weeks 17 (0.1) 8,844 (0.0) <0.001 
22-27 weeks 68 (0.4) 58,760 (0.4)  
28-31 weeks 147 (0.8) 112,407 (0.7)  
32-36 weeks 1,157 (6.7) 1,011,633 (6.1)  
More than 37 weeks 15,994 (92.0) 15,215,440 (92.8)  
Missing 290 (1.6) 313,243 (1.9)  
    
Birth weight     
>=3,000 12,171 (69.1) 11,659,487 (69.9)              <0.001 
3,000-2,500 3,973(22.5) 3,816,201 (22.9)  
1,500-2,500 1,258 (7.1) 1,026,248 (6.1)  
<1,500 226 (1.3) 178,643 (1.1)  
Missing  38 (0.2) 39,748 (0.2)  
    
Small for gestational age (10th 
centile)#   
  
 
Normal  3,681 (91.7) 3,289,125 (92.0) 0.608 
Small 331 (8.2) 287,173 (8.0)  
Data not collected  13,661 (77.3) 13,144,029 (78.6)  
*% of each category without the missing value 
# data available only in 2011 and 2012 
 
Maternal dengue slightly increased the risk of preterm birth from 7.3% to 7.9%, 
RR 1.1 (95% CI 1.0-1.2) and low birth weight from 7.2% to 8.4% RR1.2 (95% CI 1.1-
1.2), although the confidence interval was borderline. There was no association between 
maternal dengue and being small for gestational age (Table 2). Restricting analyses to 
33%, (5,755/17,388) of laboratory confirmed dengue cases did not change the magnitude 
of the associations.   
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Table 2. Number of cases notified with dengue during pregnancy (N), risk ratio crude and adjusted 
for the association among dengue during pregnancy and preterm birth, low birth weight, small for 
gestational age. Brazil, 2006-2012 
 
Table 3 shows the dose-response effect of the severity of dengue on preterm birth, 
low birth weight and small for gestational age. Dengue haemorrhagic fever in pregnancy 
doubled the odds of preterm birth from 1,191,644/16,407,084 (7.3%) to 12/79 (15.2%), 
OR 2.4 95% CI 1.3-4.4) and of low birth weight from 1,204,891/16,680,579 (7.2%) to 
11/79 (13.9%), OR 2.1 95% IC 1.1-4.0), but we did not see a significant effect of dengue 
on small for gestational age even among pregnant women who developed haemorrhagic 
disease (from 287,173/3,576,298 (8.0%) to 1/9 (11.1%), OR 2.5 95% CI 0.4-12.2).  
 
 All dengue cases  Lab confirmed dengue cases  
Outcomes  
Crude Risk Ratio 
(95 % 
Confidence 
Interval) 
Adjusted Risk 
Ratio  
(95 % 
Confidence 
Interval) 
Crude Risk Ratio  
(95% Confidence 
Interval) 
Adjusted Risk 
Ratio 
 (95% confidence 
Interval) 
 
   
Preterm birth  
N=1,193,033 
    
 N= 1,389 (0.12%)  N=439 (0.04%)  
Overall (<37 
weeks) 
1.1 (1.0-1.2) 1.1 (1.0-1.2) 1.1 (1.0-1.2) 1.1 (1.0-1.2) 
Less than 28 
weeks   
1.1 (1.0-1.1) 1.1 (1.0-1.2) 1.0 (0.9-1.2) 1.0 (0.9-1.2) 
28-32 weeks 1.2 (1.1-1.5) 1.2 (1.1-1.4) 1.2 (0.9-1.6) 1.2 (0.9-1.6) 
32-36 weeks 1.2 (1.0-1.5) 1.1 (0.9-1.4) 1.1 (0.7-1.6) 1.1 (0.7-1.6) 
     
Low birth weight  
N=1,206,375 
 N=1484 (0.12%)  N=475 (0.04%)  
Overall (<2500g) 1.2 (1.1-1.2) 1.2 (1.1-1.2) 1.2 (1.0-1.3) 1.2 (1.1-1.3) 
1500g-2499g 1.2 (1.1-1.2) 1.2 (1.1-1.2) 1.2 (1.0-1.3) 1.2 (1.1-1.3) 
Less than 1500g 1.2 (1.1-1.4) 1.2 (1.0-1.3)  1.1 (0.9-1.4) 1.1 (0.9-1.4) 
     
Small for gestational age  
N=287,504 
 N=331 (0.12%)  N=68 (0.02%)  
Overall (<10th 
centile)  
1.0 (0.9-1.1) 1.0 (0.9-1.1) 0.9 (0.7-1.1) 0.9 (0.7-1.2) 
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Table 3.   Number of cases with dengue during pregnancy (N) and Odds Ratio for the association 
Dengue during pregnancy by severity of disease and adverse birth outcomes (preterm birth, low 
birth weight, small for gestational). Brazil, 2006-2012. 
 
The risk of dengue in pregnancy on fetal outcomes depended on the time between 
dengue onset and the date of live birth: the magnitude of the effect of dengue on adverse 
birth outcomes was higher during the acute disease period, with some residual effects 
remaining after the first 10 days for preterm birth and low birth weight (Table 4).  
 
 
 
 
 
 
Outcome  
Mild dengue Odds Ratio 
(95 % Confidence Interval) 
Complicated dengue Odds 
Ratio  
(95 % Confidence Interval) 
Haemorrhagic fever Odds 
Ratio  
(95% Confidence Interval 
) 
 
   
Preterm birth (<37 weeks) 
N=1,192,920 
    
N (%) 1,234 (0.103%) 30 (0.002%) 12 (0.001%) 
Crude 1.1 (1.0-1.1) 1.4 (0.9-1.9) 2.4 (1.3-4.3) 
Adjusted  1.1 (1.0-1.1) 1.4 (0.9-2.0) 2.4 (1.3-4.4) 
     
Low birth weight (<2500g) 
N=1,206,265 
N 1,327 (0.110%) 36 (0.003%) 11(0.001%)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
Crude 1.1 (1.1-1.2) 1.6 (1.2-2.3) 2.1 (1.1-4.0) 
Adjusted 1.1 (1.1-1.2) 1. 6 (1.1-2.3) 2.1 (1.1-4.0) 
     
Small for gestational 
age (10th centile)  
N=287,474 
 
   
N  294 (0.102%) 6 (0.002%) 1(0.000%) 
Crude 1.0 (0.9-1.1) 2.2 (0.9-5.1) 2.0 (0.3-11.4) 
Adjusted 1.0 (0.9-1.1) 2.3 (1.0-5.3) 2.1 (0.4-12.2) 
Adjusted for maternal age, education, marital status  
*Because of the small numbers, we included extra decimal places.  
 
159 
 
Table 4. Number of cases with dengue during pregnancy (N) and risk Ratio for the association 
Dengue during pregnancy by timing of disease and adverse birth outcomes (preterm birth, low 
birth weight, small for gestational). Brazil, 2006-2012. 
Adjusted for maternal age, education, marital status 
*Because of the small numbers, we included extra decimal places.  
 
Discussion  
Cases of dengue haemorrhagic fever in pregnancy doubled the risk of preterm 
birth (OR: 2.4) and of low birth weight (OR: 2.1); by contrast the effect of  mild dengue 
fever only raised the risk by 10 to 20 percent for preterm birth and low birth weight 
respectively. There was no increase in the risk of small for gestational age for either 
severe or mild disease. The main dengue effect on birth outcomes occurred during acute 
disease, within the first ten days of disease onset.  
Our results are consistent those with Nascimento, et al.10 who showed that 
symptomatic dengue infection did not greatly affect the risk of low birthweight (1.00 95% 
CI 0.85-1.17) or preterm birth (OR: 0.98 95% CI 0.83-1.16) when compared to a random 
sample of live births. However, dengue has been associated with an increased risk of 
Outcome  
Risk Ratio  and frequency of outcomes  
within 10 days of disease onset 
(95 % Confidence Interval) 
Risk Ratio  and frequency of outcomes 
after 10 days from disease onset 
(95 % Confidence Interval) 
 
 
   
Preterm birth  
N=1,191,719 
    
N 75 (0.006%) 1,314 (0.110%)  
Crude 2.1 (1.7-2.7) 1.1 (1.0-1.1)  
Adjusted 2.0 (1.6-2.6) 1.1 (1.0-1.1)  
     
Low birth weight 
N= 1,206,375  
N 74 (0.006%) 1410 (0.117%) 
Crude 2.1 (1.6-2.6) 1.1 (1.1-1.2) 
Adjusted 2.0 (1.6-2.6) 1.1 (1.1-1.2) 
     
Small for gestational age (10th centile)  
N=287,173 
  
N 4 (0.001%) 83 (0.029%) 
Crude 0.5 (0.2-1.5) 1.0 (0.9-1.1) 
Adjusted  0.5 (0.2-1.5) 1.0 (0.9-1.1) 
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stillbirth, and by excluding fetal deaths in our analyses, we may be underestimating the 
risk by only considering birth outcomes in  those who survived. Our findings are also 
consistent with a meta-analyses published in 2016,2 which found an association between 
symptomatic dengue and preterm birth and low birth weight within in a hospital based 
population that sought care, and was likely to include only severe dengue cases. In our 
study, the association between maternal dengue and fetal outcomes was strongest for 
women with dengue haemorrhagic fever in pregnancy.  
There is evidence that different infectious diseases in pregnancy can lead to 
adverse outcomes. The evidence is still fragmented, and there is no consistent effect, 
which appears to vary according to the pathogen involved, and the timing and severity of 
maternal disease. For instance, studies comparing pregnant women with infection to 
pregnant women without, found a) severe influenza increased the risk of preterm birth 
from 2.4 to 4 times, whereas studies based on mild range of illness did not find an effect; 
21 b)  measles and HIV infection increased the risk of low birth weight by 3.5 and 1.6 
times, respectively. 22 23 
Our data suggest that the main way gestational dengue affects preterm birth and 
low birth weight is through maternal illness, rather than through a direct effect on the 
fetus. Since we did not observe an effect on small for gestational age, the effect of dengue 
in pregnancy on birth weight probably occurred via prematurity of the newborn. 
Therefore, much of the effect may be explained by early delivery due to medical 
interventions, such as caesarean section, required because of concern about risk to the 
mother. The risk of prematurity was higher during the first 10 days after disease onset 
and among those with haemorrhagic disease. However, data on small for gestational age 
was only available for 2011-2012, which may have affected our ability to observe an 
effect. 
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The potential study limitations are associated with the linkage process and use of 
secondary data. In relation to the use of secondary data, outcome and exposure 
identification is susceptible to misclassification, a limitation inherent to this study design. 
Estimated national prevalence of preterm birth and small for gestational age in low and 
middle income countries using the available routine collected data are underestimated, 
however this error probably affected either, those exposed and no exposed to dengue 
therefore unlikely to bias the results of this study. 24, 25  Regarding the dengue diagnosis, 
it is usual practice in outbreaks/ epidemics to test until the origin of the outbreak is clearly 
established, and after that only test when there is a clinical indication. The proportion of 
laboratory confirmed cases among general population in Brazil is around 30%, 26 and 
therefore misclassification based on the lack of laboratory confirmation is possible but 
we showed very good agreement with the estimates of risk in subsets of the data with and 
without laboratory confirmation of dengue. The linkage was rigorously validated.19 The 
results of this showed that despite the low sensitivity (that kept us from making statements 
about the prevalence of dengue during pregnancy) it is unlikely that the linkage process 
introduced bias, since missed and false matches occurred randomly. Although we 
adjusted for confounders, other possible unknown confounders, such as maternal co-
morbidities or quality or type of obstetric care, may have contributed to the association 
between severe dengue and adverse fetal outcomes.  
In summary, this study shows a more than doubling in the risk of preterm birth 
and low birth weight in women with dengue haemorrhagic fever in pregnancy, and 
increases of 10-20% in women with mild dengue. One contributing factor to adverse fetal 
outcomes may be medical interventions triggered to mitigate mothers risk associated with 
dengue haemorrhagic fever. We recommend further research in different settings to 
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confirm our results, and additional studies of adverse birth outcomes for other vector-
borne diseases.  
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Abrstract  
Dengue is a mosquito-borne disease with major public health importance  due to 
its  growing incidence and geographical spread. There is a lack of knowledge on its 
contribution to maternal death. We conducted  a population-based cohort to investigate 
the association between symptomatic dengue during pregnancy and deaths in Brazil from 
2007 to 2012. We did this by linking routine records of confirmed dengue cases to records 
of  deaths of women who had a live birth. Using the Firth method, we estimated odds 
ratios for maternal deaths associated with dengue during pregnancy. Dengue increased 
the risk of maternal death by 3 times (95%CI,1.5-5.8) and dengue haemorrhagic fever 
increased the risk of maternal death by 450 times (95%CI,186.9-1088.4) when compared 
to mortality of pregnant women without dengue. The  increase in risk occurred mostly 
during acute dengue 71.5 (95%CI,32.8-155.8), compared with no dengue cases. This 
study showed an increased risk of adverse outcomes in pregnant women with dengue. 
Therefore in areas where dengue is circulating, the health of pregnant women should be 
not only a public health priority, but health professionals attending pregnant women with 
dengue should more closely observe these patients to be able to intervene in a timely way 
and avoid deaths. 
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Introduction  
Dengue is a mosquito borne disease with a major importance in the public health 
arena due to a growing incidence (30-fold rise in the past 50 years) 1 and an expanding 
geographical range (endemic in more than 100 countries mostly in South American and 
Southeast Asia and still  spreading  to new areas, including Europe 2. According to the 
World Health Organization (WHO), approximately half of the world’s population is at 
risk 2. However the burden of dengue during pregnancy on maternal ill-health is not well 
understood. Physiological changes that occur during pregnancy (such as hemodilution) 
can mask the thrombocytopenia, leucopoenia, or hemoconcentration associated with 
dengue, and common obstetric problems can cause haematological and hepatic issues 
masking the disease. These may make it difficult to differentiate  dengue haemorrhagic 
fever from common obstetric conditions, leading to misdiagnosis 3,4.  
Dengue during pregnancy has been associated with poor fetal and maternal 
outcomes. There is some evidence that the risk of severe dengue and of hospitalization 
due to dengue is higher among pregnant compared with non-pregnant women 5 and a 
number of cases series have reported maternal deaths associated with dengue, and other 
complications such as bleeding and increased caesarean section rates 6; two small cohorts 
comparing pregnant women exposed and unexposed to dengue in Brazil and Colombia 
found more maternal deaths among the dengue exposed group 7,8.  
In this study we analysed a large population-based retrospective cohort to 
investigate these issues in greater detail and with greater power to explore the the 
association between symptomatic dengue during pregnancy and maternal mortality. 
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Methods 
We conducted a population-based retrospective cohort study by linking routine 
records of all women notified and confirmed as having dengue, with records of maternal 
deaths following delivery of a live birth, in Brazil from January 1, 2007 to December 31, 
2012.  
Data sources 
We extracted routinely collected data from three Brazilian databases.  
1) The Live Births Information System (Sistema de Informação sobre 
Nascimentos,m; SINASC), which contains records of all live births in Brazil; these data 
come from birth registration, a legal document completed by the health provider who 
assisted the delivery. It includes information on the women who gave birth such as name, 
place of residence, age, marital status, education); the pregnancy (length of gestation, type 
of delivery); and the newborn (weight at birth, the presence of birth anomalies and 
gestational age at birth) 9. The data completeness and coverage are very high, with more 
than 90% completeness for most variables and capturing 97% of Brazilian registered 
births 10,11.  
2) Mortality Information System (Sistema de Informação sobre Mortalidade; 
SIM), which contains records of all deaths in Brazil, incluing fetal deaths; these data come 
from the Death Certificate, a required legal document 12. We retained all deaths of women 
coded under obstetric causes of death by ICD-10, the "O" group. The proportion of 
records with missing data varied by variable (e.g. maternal education was missing  in 23% 
of records). Although stillbirth was not an outcome of this study, we retained all fetal 
deaths to link with maternal deaths as described below.    
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3) Notifiable Diseases Information System (Sistema de Informação de Agravos 
de Notificação; SINAN), which contains records on notifiable diseases. The dengue 
notification system includes information on the individual such as name, place of 
residence, age, sex, and years of education, on the disease, such as symptoms, laboratory 
tests, and disease severity 13. For linkage, <0.05% records were excluded because of 
missing name, and around 5% of dengue cases did not have a final classification of 
severity. Laboratory confirmation is not required to confirm dengue in Brazil. According 
to the Ministry of Health, around 30% of dengue cases were laboratory confirmed at the 
time 14. During this period, dengue was the main (and sometimes the only) vector-borne 
disease circulating in Brazil, as yellow fever and malaria occurred in restricted areas, and 
Zika and Chikungunya were not circulatingd until 2014. 
Procedures 
Maternal death records that linked with a stillbirth, a pregnancy with an abortive 
outcome, or that failed to link were excluded from analysis. Although we linked maternal 
deaths to livebirths and stillbirths, we only used the maternal deaths linked with live births 
in this study, because the comparison group was live births that occurred in Brazil during 
the study period.    
Ethical approval was obtained from The Federal University of Bahia, Salvador, 
Brazil (CAAE: 26797814.7.0000.5030) and from The London School of Hygiene and 
Tropical Medicine (Ethics Ref:10269).  
Outcomes  
We included female deaths with an obstetric code in ICD-10 recorded as the cause 
of death. The comparison group in our study was women who had a live birth in the same 
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period in Brazil who were not excluded during the linkage process described below (Fig 
1). 
  
Exposure  
The exposure under study was being a confirmed cases of dengue notified during 
a pregnancy that resulted in a live birth. In Brazil, dengue confirmation can be based on 
clinical/epidemiological criteria, namely presence of clinical symptoms of dengue in the 
same area and time as other confirmed cases of dengue, or on clinical/laboratory criteria, 
namely the presence of clinical symptoms and a positive test from one of IgM detection 
by ELISA, viral RNA detection via PCR, NS1 viral antigen detection, or positive viral 
culture15. We considered maternal deaths to be “exposed” if the woman’s records linked 
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with a live birth that was previously linked to a confirmed dengue case. We defined 
“dengue during pregnancy” as all confirmed cases of dengue (clinical/epidemiological or 
clinical/laboratorial). Laboratory confirmed cases  were referred to as “dengue during 
pregnancy, laboratory confirmed”. We used the same three clinical categories of  
classification as used by the Brazilian Ministry of Health at the time of the study: “dengue 
fever” (a self-limiting fever, with a severe headache, pain behind the eyes, muscle and 
joint pain, and rash), “complicated dengue”, and “dengue haemorrhagic fever/ dengue 
shock syndrome”. Complicated dengue is a Brazilian definition of severe cases of dengue 
that do not meet the WHO criteria for dengue haemorrhagic fever (i.e. fever, 
haemorrhagic evidence, thrombocytopenia and evidence of plasma leakage) but that 
cannot be classified as mild self-limited disease due to their severity. Complicated dengue 
is used when a probable case of dengue presents with one of the following: severe changes 
in the nervous system, cardiorespiratory dysfunction, insufficient hepatic function, 
gastrointestinal bleeding, cavity spills, or thrombocytopenia equal or less than 
50,000/mm3, leucometry less than 1000/mm 15.  
Linkage process  
We conducted the linkage in two steps. First, we probabilistically linked records 
of dengue notifications (SINAN) with records of live births (SINASC) and stillbirths 
(SIM), to identify those women who had dengue during pregnancyand who gave birth. 
For simplicity, we will refer to these as mothers even if the woman had a stillbirth. To 
link, we used the name  of the mother, two sources of age, and place of residence of the 
mother at the time of delivery or notification. We excluded records with missing names 
(Fig 1). Match weight calculations were based on the Fellegi-Sunter method16. 
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We then linked this composite births file 17 (live births/stillbirth linked with 
maternal dengue status) with maternal death records using name, age, place of residence 
of the mother at time of delivery or death, and the time between the birth of the new-born 
and death of the mother. The procedures and evaluation of the matching process are the 
subject of a separate paper. However, in brief, we expected that after excluding 
pregnancies with abortive outcomes (10% of maternal mortality notifications), the large 
majority of the maternal deaths would have linked with a live birth or stillbirth. Although 
we did not use the maternal deaths linked to stillbirth for the analyses of this paper, it is 
important to include this stage in the linkage process section to present our measure of 
error in a comprehensive way. Women coded as having an abortive outcome that linked 
to a live birth record were assumed to be a false match. Maternal deaths linking to a live 
birth and a stillbirth simultaneously were also classified as false matches, unless they 
were multiple births.  
We linked 6593 maternal deaths to the composite births file, of which 65 were 
identified as false matches. This gave a positive  predictive value (PPV)  of 6528/6593= 
99%. Of 9213 maternal deaths without an abortive outcome, we were unable to link 2,675, 
giving a sensitivity of 6,528/9213=71%. Mothers with more than 7 years of education 
and self-declared as Caucasian were more likely to link with the composite live birth 
stillbirth file.  
We further evaluated potential linkage error using dengue information obtained 
from the first linkage (between dengue and live births). We compared the maternal deaths 
classified as having dengue as a cause of death that linked with a live birth or stillbirth, 
with maternal deaths where dengue was coded as an underlying case of death-ICD-10 but 
that were not linked. There was no difference in socio-demographic characteristics 
between these two groups, suggesting that although we did not capture all of the matches 
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in our linkage, there was no selection bias associated with the exposure in our linked 
cohort. 
Statistical analysis 
Using Chi square test, we compared the characteristics of women by dengue 
status. We estimated the crude and adjusted odds ratio using the Firth method 18 (to reduce 
the small sample bias in maximum likelihood estimation) as we were analysing rare 
events, controlling for age, education and mode of delivery. For a sensitivity analysis of 
the validity of clinical/epidemiologic diagnosis, we repeated the analyses using laboratory 
confirmed dengue only. We investigated the effect of dengue severity (mild dengue, 
dengue with complications and dengue haemorrhagic fever) and time between disease 
onset and maternal deaths, since in general, dengue is an acute disease with rapid 
recovery. The time between disease onset and the outcome was calculated using the date 
of the disease onset (information available in SINAN) and the date when the outcome 
occurred (date of maternal death); we categorized this difference as being less than or 
equal to ten days or greater than 10 days.       
Data availability 
The data that support the findings of this study are available from Brazilian 
Ministry of Health but restrictions apply to the availability of these data, which were used 
under license for the current study, and so are not publicly available. Data are however 
available from the Brazilian Ministry of Health upon reasonable request.  
Results  
The Brazilian Information System recorded 10,259 maternal deaths from 2007-
2012. After exclusions, 4,053 maternal deaths in women with live births were included 
in our study population, and 12 (0.3%) had a positive dengue status (Figure 1).  The live 
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birth system recorded 17,391,826 live births from 2007-2012. After exclusions, 
14,440,229 women with live births were included in the study, and 16,224 (0.1%) had a  
dengue notification record.  
The cohort characteristics by dengue status are described in Table 1. Compared 
with women without dengue, women with dengue were more likely to have more years 
of formal education, and to have a caesarean section as a mode of delivery.  
 
Table 1. Maternal characteristics and delivery details in relation to dengue status, Brazil, 2006-2012 
Characteristics  
Notified with 
confirmed dengue 
in pregnancy 
Without dengue 
notification 
p value  
n (%) n (%)  
 
Age of the mother  
 
< 20 4,127 (25.4) 3,738,246 (25.9) <0.001 
20-35 11,011 (67.8) 9,560,187 (66.3) 
>35 1,097 (6.8) 1,129,318 (7.8) 
Missing 3 (0.0) 1,488 (0.0)  
 
Maternal education 
 
Less than 3 years    946 (5.9) 1,099,923 (7.8) <0.001 
4-7 years 4,239 (26.7) 3,867,130 (27.4) 
More than 8 years 10,710 (67.4) 9,153,016 (64.8) 
Missing  343 (2.1) 309,170 (2.1) 
    
Delivery     
Vaginal  7,599 (46.9) 7,117,183 (49.4) <0.001 
C-section  8,618 (53.1) 7,286,995 (50.6)  
Missing  21 (0.1) 25,061 (0.2)  
    
Maternal Mortality§     
Yes  12 (0.1) 4,041 (0.03) 
                           
0.00 
No 16,224 (99.9) 14,424,005 (99.97)  
    
*% of each category without the missing value 
 
 
Dengue during pregnancy tripled the risk of maternal death from 0.1% 
(16,224/14,440,229) to 0.3% (12/4,053), OR 3.0 (95% IC 1.3-5.8) (Table 2). The 
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proportion of dengue cases that were laboratory confirmed was much higher among 
maternal deaths (9/12=75%) than among mothers all of live births (5309/16224=33%). 
Restricting analyses to laboratory-confirmed cases showed that dengue increased the risk 
of maternal death almost eight fold (7.8 95% CI 3.1-15.4).  
 
Table 2 - Number of cases of dengue during pregnancy and Odds ratio crude and adjusted for the 
association between dengue during pregnancy and maternal deaths. Brazil, 2007-2012. 
Adjusted for age, education and mode of delivery   
 
 
Complicated dengue increased the odds of maternal deaths by 27 fold (95% CI 
5.5-136.3), compared with no dengue. However, this number was much higher among 
the women that developed dengue haemorrhagic fever, for whom the increase in risk of 
maternal death was 451 fold (95% CI 186-1088). 
 
Table 3.   Number of cases of dengue during pregnancy (N) and Odds Ratio crude and adjusted for 
the association Dengue during pregnancy by severity of disease and maternal deaths. Brazil, 2007-
2012. 
Adjusted for age, education and mode of delivery   
 All dengue cases  Laboratory confirmed dengue cases  
Outcome 
Crude Risk Ratio 
(95 % Confidence 
Interval) 
Adjusted Risk 
Ratio  
(95 % Confidence 
Interval) 
Crude Risk Ratio  
(95% Confidence 
Interval) 
Adjusted Risk 
Ratio 
 (95% confidence 
Interval) 
 
   
Maternal Mortality§   
Frequency 12 9 
Overall (OR) 2.7 (1.6-4.8) 3.0 (1.5-5.8) 6.4 (3.4-12.1) 7.8 (3.8-15.9) 
Outcome  
Mild dengue Odds Ratio 
(95 % Confidence Interval) 
Complicated dengue 
Odds Ratio  
(95 % Confidence 
Interval) 
Haemorrhagic fever 
Odds Ratio  
(95% Confidence 
Interval ) 
 
   
Maternal Mortality§  
    
Frequency  3 2 5 
Crude 0.8 (0.3-2.3) 28.7 (8.2-99.7) 274.5 (115.3-653.8) 
Adjusted 0.95 (0.3-3.3) 27.3 (5.5-136.3) 451 (186.9-1088.4) 
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The risk of maternal death among pregnant women with dengue depended on the 
time between first symptoms of dengue and the date of death, the deaths occurred manly 
during acute disease, 10 days between the disease onset and the date of death (Table 4).  
 
Table 4. Number of cases with dengue during pregnancy (N) and Odds Ratio for the association 
Dengue during pregnancy by timing of disease and maternal deaths. Brazil, 2007-2012. 
 
 
Pre-eclampsia or eclampsia was the registered cause of death in 25% of the 
patients with dengue; in the group without dengue, but who had a live birth, these causes 
were responsible for 19% of all deaths (appendix 1). 
In this retrospective cohort, we found that pregnant women with symptomatic 
dengue had a significantly higher risk of maternal death compared to pregnant women 
without dengue, and this risk was considerably higher when dengue was severe, 
complicated, or  dengue haemorrhagic fever. The proportion of laboratory confirmed 
cases among women who died was much higher than among the comparison group, and 
the effect of dengue on death occurred primarily during the acute disease, in the first ten 
days after disease onset.  
The results of this study are consistent with the literature that shows a higher 
maternal mortality ratio associated with dengue, mainly among those who developed 
severe dengue. In a Brazilian cohort in Rio Branco the maternal mortality ratio in the 
dengue exposed group was 13 times the mean maternal mortality ratio of the area 8 as 
Outcome  
Odds Ratio  and frequency of outcomes  
within 10 days of disease onset 
(95 % Confidence Interval) 
Odds Ratio  and frequency of 
outcomes after 10 days from disease 
onset 
(95 % Confidence Interval) 
 
 
   
Maternal Mortality§ 
Frequency 8 4 
Crude  62 (31.6-122.6) 1.0 (0.4-2.6) 
Adjusted  71.5 (32.8-155.8) 0.9 (0.3-3.1) 
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opposed to our finding of 3 times higher. The percentage of maternal deaths among 
pregnant women with dengue in the case series studies varied from 6.6% in Sri Lanka 19 
to 21.7% in the South Sudan 6, whereas we see  0.07%. This may be because we included 
less severe disease or excluded women with stillbirth or other abortive outcomes and 
because of our low sensitivity (71%) to detect dengue. Among women with severe disease 
and a live birth, the rate was 0.12%. The mechanism for the association between dengue 
and maternal deaths is not clear:  one possible explanation is that the clinical aspects of 
the disease may be different during pregnancy in a way that increase the susceptibility to 
dengue haemorrhagic fever. In Brazil pregnant women with dengue were 3 times more 
likely to develop severe dengue than non-pregnant women5. Another hypothesis is that 
physiological changes occurred during pregnancy such as hemoconcentration and the 
difficultly in distinguishing between severe dengue and common obstetric conditions may 
lead to misdiagnosis and delay the disease treatment that can progress to hypovolemic 
shock and death. A meta-analysis of the effect of infection on pregnancy showed that 
viral infections can increase the risk of  pre-eclampsia, although this study does not 
mention dengue.  It is possible that dengue virus leads to the same etiologic pathway of 
inflammatory modifications of placental tissues tht 20. Pre-eclampsia was the cause of 
death in 25% of the patients with dengue, compared with 19% in the comparison group. 
There is  growing  evidence that different infectious diseases during pregnancy 
can be associated with adverse outcomes. The evidence is still fragmented and the effect 
of different infections appear to vary according with the pathogen involved and the 
severity of maternal disease. According to a meta-analysis, pregnant women with active 
tuberculosis tended to be more liked to suffer a maternal death although this was not 
significant (OR:4, 95% CI 0.65-25.2)21, and pregnant women with measles had a 9-fold 
increased risk of maternal death 22.   
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The potential study limitations are associated with the linkage17, although we 
undertook  a rigorous validation process that showed that despite the low sensitivity, that 
kept us from making statements about the prevalence of dengue during pregnancy, it is 
unlikely that the linkage process introduced bias in the measure of association since 
missed and false matches occurred randomly in the population. The maternal death 
linkage analysis comparing dengue cases that the algorithm was capable of capturing, 
with those that it could not, but recorded maternal death as cause of death, showed no 
difference between the two groups, however this result should be interpreted with caution 
because it had limited power, due to the sample size. There are some limitations 
associated with the use of secondary data: we only  had a limited number of possible 
confounders to analyze. Although we adjusted for these,  unknown confounders, such as 
maternal co-morbidities or quality of care, may have contributed to the association 
between severe dengue and maternal deaths.  
In summary, this study suggests a marked increase in the risk of maternal deaths 
in women with dengue during pregnancy. The health of pregnant women is a public health 
priority, but in places where dengue is circulating and the health professionals attending 
pregnant women with dengue should observe them more closely to be able to intervene 
in  a timely way, and avoid death. We recommend further research in different settings to 
confirm our results and studies of negative fetal and maternal outcomes in other vector-
borne diseases.  
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Appendix1: Table characteristics women that died with dengue 
 Age Education  Mode of 
delivery 
Cause of death Lab  severity 
1 29 More than 12 
years of formal 
education 
C-section  Other viral diseases complicating 
pregnancy, childbirth and the 
puerperium (dengue registered as 
underline cause) 
Yes Haemorrhagic 
disease  
2 34 4-7 years of 
formal 
education 
C-section  Other viral diseases complicating 
pregnancy, childbirth and the 
puerperium (dengue registered as 
underline cause)  
Yes Haemorrhagic 
disease 
3 17 8-11 years of 
formal 
education 
C-section  Cardiac complications of 
anaesthesia during the 
puerperium 
No Mild disease 
4 19 8-11 years of 
formal 
education 
C-section  Other viral diseases complicating 
pregnancy, childbirth and the 
puerperium 
Yes Haemorrhagic 
disease 
5 30 8-11 years of 
formal 
education 
C-section  Other viral diseases complicating 
pregnancy, childbirth and the 
puerperium 
Yes Dengue with 
complications 
6 18 8-11 years of 
formal 
education 
Vaginal Eclampsia complicating the 
puerperium 
Yes Mild disease 
7   C-section  Diseases of the respiratory 
system complicating pregnancy, 
childbirth and the puerperium 
No  
8   C-section  Complication of the puerperium, 
unspecified 
No  
9 25 8-11 years of 
formal 
education 
C-section  Other viral diseases complicating 
pregnancy, childbirth and the 
puerperium 
Yes Haemorrhagic 
disease 
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10 16 8-11 years of 
formal 
education 
C-section  Other specified diseases and 
conditions complicating 
pregnancy, childbirth and the 
puerperium (dengue registered as 
underline cause) 
Yes Haemorrhagic 
disease 
11 25  C-section  Eclampsia, unspecified as to time 
period 
Yes Dengue with 
complications  
12 29  C-section  Severe pre-eclampsia Yes Mild disease 
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Discussion section  
Overview    
The overall aim of this thesis was to explore the relationship between adverse 
pregnancy outcomes and symptomatic maternal dengue. This was achieved through 
taking the following steps: first I developed a linkage algorithm to assess exposure 
(dengue status) (paper 2 and 3); then I evaluated the quality of the linkage to ensure that 
it did not affect the measure of association obtained in the following step (paper 2 and 3); 
and finally I used the linked data to estimate the association between dengue during 
pregnancy and adverse maternal and fetal outcomes (paper 4, 5, 6).  
This chapter contains two main sections. In the first, I summarize the key linkage 
challenges and main findings of each results chapter and discuss the interpretation and 
biological plausibility of this relationship. Second, I discuss the implications of this work 
in the public health arena, as well as make recommendations for future research.    
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Chapter 9. Final discussion, conclusion and recommendations  
Summary of linkage challenges and strength   
 Data linkage of population level data is an important tool that can be used to 
answer a range of research questions, especially regarding the relationship between 
prenatal maternal risk and adverse birth outcomes. In this thesis, as mentioned before, 
previous studies on dengue during pregnancy have been shown to be inefficient as they 
lacked sufficient power to perform sensitivity analyses due to insufficient sample size. 
The use of administrative collected data is a valuable alternative.   
Although Brazil has a long tradition in collecting administrative data of relatively 
good quality, especially for a middle-income country, the linkage pre-processing stage 
can be challenging for a large datasets, because it is important to inspect, identify and 
recognize the patterns of error to be able to deal with them. For example, in the present 
linkage, after inspection I identified known prefixes such as Mr and transformed them 
into the real name Maria. An additional valuable contribution of data inspection is to 
identify common names, to be able to attribute a different weight score to them because 
a linkage error is more likely to occur with these names than with less common names.         
 Another important challenge of the present linkage was linking records belonging 
to different individuals, in this case mothers and babies. The most important barrier to 
linking maternal and baby records is the limited availability of common and complete 
personal identifiers. This thesis used three identifiers to link the records (name, age and 
residence of the mother), and this is one of the causes of the relatively low sensitivity, 
because in same cases it was not passible to tell which record was the correct match, and 
so no link was made. 
 A further complication emerged in the linkage performed in this thesis. The linked 
datasets did not overlap exactly, there was no Gold-Standard data available and the 
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expected number of matches was unknown because the incidence of dengue during 
pregnancy can vary from place to place. This makes it difficult to estimate the linkage 
accuracy and evaluate the error associated with the linkage. To overcome these 
challenges, I created a “Gold-standard” dataset using nine steps (paper 2); this was 
possible because I had access to identifiable data. It enabled me to demonstrate the 
accuracy of the linkage and because I had additional information about the characteristics 
of the cohort, I also checked for potential bias. This was in fact a real strength of my 
study, that I had access to the identifiable data and I was able to evaluate the quality of 
the linkage.              
Summary of main findings 
 Mild dengue during pregnancy roughly doubled the risk of stillbirth, using a set 
of live births as control group. In contrast, dengue only elevated the risk of preterm birth 
(PTB) and low birth weight (LBW) respectively by 10 to 20 percent; however, the 
confidence interval was borderline. There was no increase in the risk of small for 
gestational age. In the maternal mortality analyses, I showed that pregnant women with 
symptomatic dengue had a threefold higher risk of maternal death compared to pregnant 
women without dengue (Table 1).  
 To address the potential misclassification of dengue due to the absence of 
laboratory confirmation, I performed an analysis using only laboratory confirmed cases. 
Laboratory confirmed dengue during pregnancy did not change the magnitude of the 
association between dengue and the adverse fetal outcomes (stillbirth, preterm birth, low 
birth weight and small for gestational age). However, the proportion of laboratory 
confirmed dengue cases among women who died was higher than in the comparison 
group (women who delivered a live birth and did not die). The risk of maternal death 
among laboratory confirmed dengue cases was 61% higher than non-laboratory 
190 
 
confirmed cases. We suggest that women with severe dengue were more likely to have 
had a laboratory test requested by their prenatal carers.      
 The literature has shown that the effects of infectious disease on maternal and fetal 
outcomes appear to vary with the severity of the maternal illness 1. The magnitude of the 
association varies depending on severity of the maternal illness for all pregnancy 
outcomes. In the stillbirth analyses, the risk of stillbirth among severe cases was 2.9 times 
higher than mild cases and almost 5 times higher than the controls. Cases of dengue 
haemorrhagic fever increased the risk of preterm birth and low birth weight twofold 
compared to non-dengue live births, although even the most severe category of dengue 
(DHF/DSS) did not have an effect on small for gestational age. The risk of maternal death 
among women with complicated dengue and DHF/DSS was 451 times higher than in 
cases of non-dengue pregnant women.   
 Dengue is an acute infection with low burden of chronicity 2. Because of this the 
hypothesis was that the magnitude of association would be higher in the first days after 
the disease onset, so time would act as an effect modifier of the association. I tested this 
hypothesis and the magnitude of the association was modified by the time between the 
disease onset and the pregnancy outcome. An excess of negative fetal and maternal 
outcomes during the acute disease was found. The risk of stillbirth, preterm birth and low 
birth weight among cases of women with dengue that occurred within 10/20 days of 
disease onset was more than 2 times higher than cases of women with dengue that 
occurred after this period. Regarding maternal deaths, the risk of death within 10 days of 
disease onset was 75 times higher than in the comparison group.    
 
 
 
191 
 
 
 
 
Table 1. Summary of main findings   
 Odds/Risk 
Ratio of 
stillbirth 
(95 % 
Confidence 
Interval) 
Odds/Risk 
Ratio of  PB 
(95 % 
Confidence 
Interval) 
Odds/Risk 
Ratio of  
LBW 
(95 % 
Confidence 
Interval) 
Odds/Risk 
Ratio of  SGA 
(95 % 
Confidence 
Interval) 
Odds/Risk Ratio 
of  MM 
(95 % Confidence 
Interval) 
      
Dengue during pregnancy 
 
 1.9(1.6-2.2) 1.1 (1.0-1.2) 1.2 (1.1-1.2) 1.0 (0.9-1.1) 3.0 (1.5-5.8) 
      
Dengue during pregnancy laboratory confirmed 
 
 1.9(1.6-2.2) 1.2 (1.0-1.3 1.3 (1.1-1.4) 0.9 (0.7-1.2) 7.8 (3.8-15.9) 
      
Dengue during pregnancy categorized by severity 
 
Mild dengue 1.7 (1.5-2.0) 1.1 (1.0-1.1) 1.2 (1.1-1.3) 1.0 (0.9-1.1) 0.9 (0.3-3.3) 
      
Complicated dengue - 1.4 (0.9-2.1) 1.7 (1.2-2.4) 2.4 (1.0-5.6) 27.3 (5.5-136.3) 
      
Dengue 
haemorrhagic fever  
- 2.4 (1.3-4.5) 2.1 (1.1-4.1) 2.5 (0.4-14.4) 451 (186.9-1088.4) 
      
Severe dengue 
(complicated 
+haemorrhagic ) 
4.9 (2.3-10.2) - - - - 
      
Dengue during pregnancy categorized by length of time between symptoms and outcome  
      
Less than 20 days  4.9 (3.2-7.5) 2.0 (1.6-2.6) 2.0 (1.5-2.6) 0.5 (0.2-1.5) 71.5 (32.8-155.8) 
      
More than 20 days 1.7 (1.4-2.0) 1.1 (1.0-1.1) 1.1 (1.1-1.2) 1.0 (0.9-1.1) 0.9 (0.3-3.1) 
  
Interpretation of main findings  
To our knowledge, this is the first study to investigate the risk of stillbirth, small 
for gestational age and maternal deaths among women with dengue during pregnancy 
using a population-based approach with a sufficiently large sample size and controlling 
for confounders and to investigate the effect of disease severity and time between the 
disease onset on preterm birth and low birth weight.   
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The results of our study are consistent with the current literature. A hospital-based 
study conducted in French Guiana found that women with symptomatic dengue had a 
higher frequency of stillbirth and an increased risk of preterm birth and low birth weight. 
In this study, the point estimative for PTB and LBW was above two; however, the 
confidence interval was borderline 3. In this thesis, although dengue slightly elevated the 
risk of PTB and LBW by 10 to 20 percent, the confidence interval overlapped with results 
presented by Nascimento et al. 4 who showed that symptomatic dengue infection did not 
affect the risk of low birthweight (1.00 95% CI 0.85-1.17) or preterm birth (OR: 0.98 
95% CI 0.83-1.16) when compared to a random sample of live births. Our findings are 
also consistent with a meta-analyses published in 2016 5, which reported an association 
between symptomatic dengue and stillbirth, preterm birth and low birth weight in hospital 
based studies. Hospital based studies selected the population that sought care, therefore 
they are more likely to include severe dengue cases. As shown in our findings, severe 
cases had a consistent increase in the risk of fetal outcomes, except SGA. The maternal 
outcome results were also consistent with the literature. In a Brazilian cohort in Rio 
Branco, the maternal mortality ratio in the dengue exposed group was 13 times the mean 
maternal mortality ratio of the area 6 as opposed to our finding of 3 times higher. 
However, it is important to highlight that this study had only two maternal deaths in the 
dengue group and their small sample might have overestimated the results.  
Biological Mechanisms  
Investigating the potential mechanism of how dengue may cause adverse 
pregnancy outcomes is not simple because dengue infection is often not apparent from 
the case history or physical examination of the mother or fetus. Further information from 
histological evaluation of the placental and fetal autopsy is difficult to obtain, and there 
is no data from animal studies to provide a picture of how dengue infection results in 
adverse pregnancy outcomes.  
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It is unknown whether these adverse pregnancy outcomes are related to the direct 
effect of fetal infection or the maternal response to viremia. Stillbirth, for example could 
be a result of maternal or fetal infection due to a diversity of mechanisms, e.g. direct 
infection of the fetus, placental damage or severe maternal illness 7. According to the 
results obtained in this thesis and publications available on effects of maternal infection 
on the fetus, there are potential plausible biological pathways from dengue infection, 
which may result in negative pregnancy outcomes.  
 The analyses of disease severity and length of time between symptom onset and 
adverse pregnancy outcome showed that the risk was higher during acute maternal illness 
suggesting that the main pathological pathway involved in this association is acute 
maternal illness. In this case, maternal high fever, or systematic symptoms of dengue such 
as vascular leak syndrome, mucosal bleeding, and lethargy or immunological reactions to 
fight the virus can be deadly to the fetus without the organisms ever being transmitted to 
the placenta or fetus. The lack of association between dengue and small for gestational 
age also corroborates the fact that dengue probably does not cause chronic effects after 
the mother’s health has been reestablished.    
 Other mechanisms can also be present such as direct damage to the fetus or 
placental circulation 8. The vertical transmission of dengue has not been described 
frequently, nevertheless, the virus and anti-dengue antibodies have been found in 
placentas, in cord blood of infants and in the cells of lung and kidney of an aborted fetus 
9 10 11 12 13 14 15. In a few cases, endothelial damage and increased vascular permeability 
due to DHF may facilitate passage across the placental barrier thus contributing to vertical 
transmission of dengue infection 16. Once the virus reaches the placental tissue, 
pathological changes might be produced such as villous stromal edema, an increase in the 
formation of syncytial knots and chorangiosis, resulting in hypoxia 10 9 8.  
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The results of this thesis have not revealed an important association between mild 
dengue disease and preterm birth, therefore it is unlikely that  the immunological reaction 
of the body against the dengue virus increases the production of pro inflammatory 
cytokines, including interleukin-6 (IL-6), interleukin-8 (IL-8), tumour necrosis factor α 
(TNF-α) 17 at levels capable of activating uterine contractions culminating in a preterm 
delivery 18 19. Even among those who had hemorrhagic fever, in part these outcomes may 
be explained by early delivery due to medical intervention required because of risk to the 
mother.  
 I propose three potential explanations for the association between dengue and 
maternal deaths; however, the analyses performed in this PhD cannot discard nor support 
any of them. First, the clinical characteristics of the disease may be different during 
pregnancy such that it increases susceptibility to severe disease. In Brazil pregnant 
women with dengue were 3 times more likely to develop severe dengue than non-pregnant 
women 20. This could be explained by the shifts in the pregnant immunological system, 
from Th1 to Th2 that can result in infection susceptibility 21. Another hypothesis is that 
the physiological changes which occur during pregnancy such as hemoconcentration and 
the difficultly in distinguishing between severe dengue and common obstetric conditions 
may lead to misdiagnosis and delay the disease treatment which might lead to 
hypovolemic shock and death. Finally, studies have shown an increase in the risk of pre-
eclampsia among pregnant women with viral infection.  It is possible that the dengue 
virus leads to the same etiologic pathway of inflammatory modifications observed in 
pregnant women with cytomegalovirus infection, which is upregulated TLR-2/-4mRNA 
expression and increased levels of IL-6 and TNF- α, and reduced IL-10 compared to 
matched normal and no pregnancy controls of placental tissues 22,23.  
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Limitations  
 Specific limitations have been discussed in each paper. Overall, the main 
limitations to the work presented in this thesis lies in the use of administrative data and 
the linkage process. Regarding the use of secondary data: the proportion of preterm births 
recorded in SINAN-Brazil was found to be underestimated by 15%, and misclassification, 
based on the criteria used to assess the gestational age at birth information (date of the 
last period), could have occurred. However, these errors probably affected both those 
exposed and not exposed to dengue therefore; this is unlikely to bias the results of this 
study. If this assumption is not correct and preterm birth was underestimated differently 
by exposure status, it either could bias the results in an underestimation (if it was 
underestimated in the exposed group) or overestimated (if it was underestimated in the 
non-exposed group).   
Regarding dengue, studies have shown that dengue surveillance substantially 
underestimates the disease burden, mainly during periods of low-transmission. I assume 
that the underestimation of the disease incidence is a non-differential error, therefore our 
results could be underestimated, i.e. the magnitude of the association found could be even 
higher than the magnitude presented in this thesis. Similar to differential error of the 
outcome measurement, if differential misclassification of dengue status occurred, it could 
have resulted in either underestimation or overestimation depending on the situation. For 
example if the comparison group were less likely than the cases to be classified as a 
dengue case, it would lead to overestimation of the measure of association. 
Misclassification of exposure based on the lack of laboratory confirmation is also possible 
but very good agreement with the estimates of risk in subsets of the data with and without 
laboratory confirmation of dengue were found, except in the maternal mortality analyses.  
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Another limitation is the restricted availability of potential confounders (e.g. 
hospital admission, maternal co-morbidities, quality of obstetric care), and some variables 
available were already categorized, consequently restricting information, such as 
gestational age, which was recorded as a categorical variable until 2010. Finally, although 
I used massive numbers of routinely collected data, in some of the analyses, especially 
for severe disease, the sample sizes were small, although given the large effect size I still 
have enough power in most of the analyses.       
 The linkage process posed a number of challenges, such as linking different 
individuals (mother-baby) due to the limited numbers of identifiers; estimating the 
linkage accuracy due to the absence of Gold standard dataset or the unknown number of 
matches that are discussed in detail in chapters 4 and 5. The main limitation inherent to 
this process is the low sensitivity (that kept us from making statements about the 
prevalence of dengue during pregnancy). However, it is unlikely that the linkage error 
introduced bias in the final analyses, since the evaluation of the linkage showed that 
missed and false matches, used to assess the exposure status, occurred randomly.  
 Implications and recommendations  
The linkage process was done very carefully and it proved to be as accurate as 
possible. The performing linkage of complex data records requires substantial expertise 
(which I have developed during my PhD) which can be applied to answer different 
research questions. It can be used to evaluate policy implementation in places where 
population level identified data are available. An example in Brazil is the recently 
developed Center of Data and Knowledge for Health (CIDACS), which is developing 
numerous research projects with routine data and some of the techniques developed in 
this thesis, can be applied there. Even though the linkage technique used in this thesis can 
be applied in other studies and different settings, it should be done cautiously, since some 
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linkage decisions were made based on the characteristics of these particular datasets. For 
example, the string comparator used was chosen because it performed better in comparing 
names in Brazil. Names from different places could possibly use another string 
comparator.   
  Due to disclosure issues, fragmentation of the data has been a common practice 
to keep identifiers separate from attributes. This can however, increase the risk of bias in 
the analyses since linkers and analysts may not be aware of important disproportions that 
affect the quality of the linkage. Given that I was in a unique position when I performed 
the linkage and the posterior analyses, I recommend that when possible, the linkage 
process when not developed by the same person should be closely monitored by the 
analysts of the linked data. The data linkers should have access to the characteristics of 
the data, so they can be aware of potential problems and share this information with 
analysts to be incorporated into results.   
This thesis can be reproduced in other setting and it is likely that the results on the 
association between dengue and pregnancy outcomes will be the same as observed in this 
cohort or an even higher magnitude of association can be observed if the surveillance 
system performs better than the Brazilian system. Perhaps in settings where the frequency 
of severe cases is even higher than in Brazil (e.g. countries in Southeast Asia), the 
sensitivity analyses by severity can make use of a bigger sample size than that observed 
in this research and provide greater precision.     
Since dengue is a vector borne disease without recommended vaccine for pregnant 
women, the health of this group should be a public health priority in places where dengue 
is circulating. Not only this but measures to stimulate self-protection from mosquitos bites 
should be reinforced. Dengue control programs should strengthen health educational 
actions on effective methods to protect the population, such as using air conditioning, 
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screens, or nets when indoors, wearing long sleeves and trousers, using permethrin-
treated clothing and gear, and using insect repellents when outdoors. However, there is 
not enough evidence of the efficacy of these measures.     
Mosquito control measures is also important to reduce the incidence of the disease 
and consequently reduce the risk of adverse pregnancy outcomes. Currently, Aedes 
mosquito control depends on mechanical breeding-site reduction and chemical pesticides 
(insecticides and larvicides), measures that have failed to stop dengue and other arbovirus 
disease from spreading in Brazil.  Alternative methods have been proposed and tested in 
Brazil, such as RIDL (Release of Insects with Dominant Lethality). These have achieved 
a 95% reduction in local Aedes populations and Wolbachia , that has been tested in open 
field and mathematical models predict that one strain would reduce the basic reproduction 
number of DENV transmission by 70%. However, these alternative methods are not part 
of the arboviruses control program of the Brazilian Ministry of Health.     
As dengue prevention is not straightforward and mosquito control has failed in 
Brazil, the results shown in this thesis point to the crucial role of the clinical management 
of dengue in pregnant women. Doctors and medical staff in general attending to pregnant 
women with dengue should closely observe and monitor the patients to be able to 
intervene timely and avoid death of the mother or fetus, especially during the acute phase. 
For further investigation, I recommend careful observation and notation of dengue in 
antenatal records and full dengue investigation of adverse pregnancy outcomes, 
especially maternal and fetal deaths. 
Further research is required in different settings to confirm the results presented 
in this thesis and examine childhood outcomes. Additional studies are required to measure 
the burden of subclinical maternal viral infections on pregnancy outcomes, the effect of 
different dengue serotypes, and the effect of other vector-borne diseases, such as 
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chikungunya, yellow fever and West Nile disease. Another important research 
recommendation is to elucidate the pathological mechanisms involved in this association 
including animal and in vitro models. 
 Conclusion   
In summary, this thesis shows there is an increase in the risk of stillbirth and 
maternal deaths in women with mild dengue during pregnancy. Severe disease increases 
the magnitude of the association with deadly maternal and fetal outcomes and doubles 
the risk of preterm birth and low birth weight. Therefore, pregnant women should be 
included as an at-risk population in dengue control programmes in order to reduce the 
risk for women and fetal outcomes.  
The proposed objective of the thesis was achieved; I was able to develop and 
evaluate a linkage process addressing the challenges that arose from the complex data and 
estimate the association between dengue and pregnancy outcomes. This thesis is a 
document that adds an important piece in the puzzle of the effects of maternal viral 
infection on pregnancy outcomes, showing that symptomatic dengue during pregnancy is 
associated with adverse outcomes. During this journey, I also developed expertise in data 
linkage and built up my skills as an epidemiologist.  
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